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Abstract 
 
Inflammatory Bowel Diseases (IBD) are a group of chronic inflammatory diseases 
of the gastrointestinal tract with a high degree of incidence worldwide. Nowadays, a 
specific treatment of IBD is still not available and the most currently drugs used in its 
treatment are associated with significant side effects that limit their use. The lack of 
effectiveness and the adverse effects of standard therapies have increased the need 
for searching new treatment strategies that combine efficacy and safety. 
Dietary polyphenols have been shown to exert beneficial effects on human health 
but the underlying mechanism are still a matter of controversy. Initially though to be 
antioxidants in vivo, because of extensive biotransformation and poor bioavailability, 
it is now widely accepted that this is an unlike activity mediating their biological 
impact. 
In fact, it has been shown that the anti-inflammatory effect of polyphenols 
(among others) cannot be merely explained on basis of their antioxidant capacity 
and it is now known that the redox regulation of several signal transduction 
pathways must be implied to explain their cellular effects.  
Red wine is very rich in these phenolic compounds and in the last years numerous 
studies described health-promoting effects of this beverage, including anti-
inflammatory proprieties, but the molecular mechanisms underlying its protective 
role remain largely unknown. A clear understanding of the molecular mechanisms of 
action of polyphenols is crucial in the valuation of these potent molecules as 
potential prophylactic and therapeutic agents in IBD. 
Given the fact that the gastrointestinal tract is a compartment where the dietary 
polyphenols reach high concentrations in a non-modified structure this work 
pretends to evaluate the potential anti-inflammatory effect of a red wine 
polyphenolic extract (RWE) in gastrointestinal inflammation and investigate which 
are the mechanisms involved in its anti-inflammatory action. Particularly, to 
determine if RWE have the capacity to modulate nitric oxide fluxes, activate the Nrf2 
pathway leading to the induced expression of cytoprotective genes and also affect 
the NF-­‐κB pathway using cultured intestinal cell models.  
Overall, results suport that RWE have a protective effect against inflammation not 
compromising cell viability. Mechanistically, this conclusion is supported by the 
interference with cellular inflammatory pathways, inhibiting the production of 
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inflammatory mediators. In fact, RWE inhibited IκB degradation induced by TNF-α, 
partially suppressed TNF-α -induced IL-8 overproduction and prevented the iNOS 
protein expression induced by cytokines, thus leading to a significant reduction in 
●NO overproduction. RWE also reduce the levels of tyrosine nitration and alter 
occludin expression and distribution. Furthermore RWE also have an effect in the 
Nrf2 pathway increasing its translocation to the nucleus and the expression of its 
target genes. 
 
Keywords: Inflammatory Bowel Diseases; Red Wine polyphenolic extract; Anti-
inflammatory effects; Nitric Oxide; Nrf2.   
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Resumo 	  
As Doenças Inflamatórias Intestinais (DII) são um grupo de doenças inflamatórias 
graves do trato gastrointestinal com um elevado grau de incidência na população 
mundial. Atualmente ainda não existe um tratamento específico para DII e os 
fármacos mais frequentemente usados no seu tratamento estão associados a efeitos 
adversos significativos que limitam o seu uso. A falta de efetividade e os efeitos 
adversos das terapias atuais têm aumentado a necessidade de procurar novas 
estratégias terapêuticas que combinem eficácia e segurança. 
Os polifenóis da dieta têm vindo a demonstrar exercer efeitos benéficos para a 
saúde humana mas os mecanismos moleculares subjacentes são ainda tema de 
controvérsia. Inicialmente pensava-se que estes compostos atuassem como 
antioxidantes in vivo mas devido à sua extensa biotransformação e reduzida 
biodisponibilidade é agora aceite que o seu impacto biológico não se deve 
meramente a esta característica.  
De facto, foi provado que os efeitos anti-inflamatórios (entre outros) dos 
polifenóis não podem ser somente explicados pela sua capacidade antioxidante e 
sabe-se agora que a regulação redox de várias vias de transdução de sinal devem 
estar implicadas na explicação dos seus efeitos celulares.  
O vinho tinto é muito rico nestes compostos e nos últimos anos numerosos 
estudos descreveram efeitos benéficos para a saúde tais como propriedades anti-
inflamatórias, no entanto os aspectos fundamentais dos mecanismos de ação 
moleculares subjacentes à sua ação protetora permanecem ainda por  esclarecer. 
Uma clara compreensão dos mecanismos moleculares de ação dos polifenóis é 
crucial na validação destas promissoras moléculas como potenciais agentes 
profiláticos e terapêuticos em DII.  
Dado que o trato gastrointestinal é um compartimento em que os polifenóis da 
dieta atingem concentrações elevadas numa estrutura não-modificada, este trabalho 
pretende avaliar o potencial efeito anti-inflamatório de um extrato polifenólico de 
vinho tinto (EVT) na inflamação gastrointestinal e investigar quais os mecanismos 
envolvidos neste efeito. Particularmente determinar se os EVT possuem a capacidade 
de modular fluxos de óxido nítrico, ativar a via do Nrf2 levando à indução da 
expressão de genes citoprotetivos e também afectar a via do NF-­‐κB usando um 
modelo de células intestinais, as células HT-29.  
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Globalmente, os resultados demonstram que os EVT possuem um papel protetor 
contra a inflamação não comprometendo a viabilidade celular. Esta conclsuão é 
mecanisticamente suportada pela intereferência com vias celulares de inflamação. 
De facto, o EVT inibiu a degradação de IκB induzida por TNF-α, suprimiu 
parcialmente a sobreprodução de IL-8 e preveniu a expressão de iNOS induzida por 
citocinas o que levou a uma significativa redução da sobreprodução de ●NO. O EVT 
também diminui os níveis de nitração de tirosina e a expressão de ocludina foi 
reduzida e alterada. Para além disso EVT também afectam a via de sinalização do 
Nrf2 aumentando a sua translocação para o núcleo e aumentando a expressão dos 
seus genes alvo.  
 
Palavras-chave: Doenças inflamatórias intestinais; Extratos polifenólicos de vinho 
tinto; Efeitos anti-inflamatórios; Óxido Nítrico; Nrf2.  
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Chapter 1: Introduction  
 
1.1 - Inflammatory Diseases of the Gastrointestinal 
Tract 
 
Inflammatory diseases of the gastrointestinal (GI) tract comprehend a great 
variety of illnesses with different symptoms and manifestations in the different parts 
of the GI tract. Gastrointestinal inflammation influences the function of the mucosal 
layer that lies closest to the luminal contents and also alters the ability of the mucosa 
to resist injury and its capacity to undergo repair once injury has occurred (Wallace 
J. L. et al, 2001). 
 
1.1.1 - Inflammatory Bowel Diseases  
 
 -Definition and etiology 
 
Inflammatory bowel diseases (IBDs) are a group of chronic inflammatory diseases 
of the gastrointestinal tract which major forms are ulcerative colitis and Crohn’s 
diseases that have been well characterized by clinical, pathological , endoscopic and 
radiological features (Xavier R. J. et al, 2007). These diseases are characterized by a 
deregulated synthesis and release of a variety of proinflammatory mediators, 
including cytokines, reactive oxygen species (ROS) and nitric oxide (●NO), resulting 
in a disruption of epithelial barrier, excessive tissue injury and persistent 
inflammatory state (Scaldaferri F. et al, 2007).  
The etiology of IBD remains unclear but is thought to involve a combination of 
environmental, genetic and imunobiological factors. Both ulcerative colitis and 
Crohn’s diseases are polygenic diseases, genome-wide scans have identified multiple 
genes that contribute to diseases susceptibility. Genetic factors discovered to date 
affect barrier function and innate and adaptive immunity (Xavier R. J. et al, 2007).  
The onset of IBD typically occurs in the second and third decades of life. The 
existent data suggest that the worldwide incidence rate of ulcerative colitis varies 
greatly between 0.5–24.5/100,000 persons, while that of Crohn’s disease varies 
between 0.1–16/100,000 persons worldwide, with the prevalence rate of IBD 
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reaching up to 396/100,000 persons (Lakatos P.L., 2006). This group of diseases 
compromise severely the life quality of patients and could also be a risk factor to the 
development of other pathologies such as colorectal cancer. 
-Major forms 
 
Ulcerative colitis  
Ulcerative colitis is a relapsing, non-transmural inflammatory disease restricted to 
the colon. It is characterized by severe inflammation and concomitant production of 
a complex mixture of inflammatory mediators with the development of extensive 
superficial mucosal ulceration. Histopatological features include the presence of a 
significant number of neutrophils within the lamina propria and the crypts where 
they form micro-abscesses (fig.1). Depletion of goblet cell mucin is also common 
(Baumgart D. C. et al, 2007).  
 
Crohn’s disease 
Crohn’s disease is a relapsing transmural inflammatory disease of the 
gastrointestinal mucosa that can affect the entire gastrointestinal tract. Usual 
presentations include the discontinuous involvement of various portions of the 
gastrointestinal tract and the development of complications including strictures, 
abcesses or fistulas. This disease is characterized by aggregation of macrophages 
that frequently form non-caseating granulomas (fig. 1) (Baumgart D. C. et al, 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: “Histologic hallmarks of IBD: clues to immunopathogenesis. Left panel, Crohn’s 
disease—biopsy from a terminal ileum with active disease. The figure illustrates a discrete 
granuloma composed of compact macrophages, giant cells and epithelioid cells. Surrounding 
the nodule there is marked infiltration of lymphoid cells, plasma cells and other inflammatory 
cells, but there is no necrosis. Right panel, Ulcerative colitis—colonic mucosal biopsy taken 
from a patient with active disease. The crypt abscess is composed of transmigrated 
neutrophils and the surrounding epithelium exhibits features of acute mucosal injury” (Xavier 
R. J et al, 2007). 
	   15	  
1.1.2 - The intestinal barrier in IBD 
 
The intestinal barrier is a dynamic and complex structure that ensures the 
intestinal homeostasis separating the intestinal contents from the host tissues, 
regulating the nutrient absorption and allowing interactions between the resident 
bacterial flora and the mucosal immune system. This barrier is composed by a thick 
mucus layer containing antimicrobial products, intestinal epithelial cells (IECs) and an 
underlying set of cells (mesenchymal cells, dendritic cells, lymphocytes and 
macrophages) (Roda G. et al, 2010). 
 
Mucus layer 
 
The mucus layer is synthesized by goblet cells and it is composed of a large and 
complex variety of molecules. It acts as a chemical barrier preventing pathogen 
invasion. The viscosity of the mucus given by the presence of glycosylated mucins 
and trefoil factors (TFFs) is the most important feature in the protection of the 
mucosa. Other constitutive elements of the mucus are secretory immunoglobulins 
produced by B-lymphocytes, antimicrobial peptides, such as defensins and lectins, 
secreted by Paneth cells, antimicrobial protease inhibitors synthesized by epithelial 
cells and enterocyte hydrophobic phospholipids. In IBD is observed a decrease in the 
mucus viscosity with reduction of TFFs and the thinning of the mucus layer what 
leads to a lessened capability of the mucus layer to limit antigenic traffic and 
bacterial translocation in the lamina propria (Roda G. et al, 2010). 
 
Epithelial junctions 
 
The intestinal permeability is regulated through the epithelial junctions consisted 
by desmosomes, adherent junctions (AJs) and tight junctions (TJs). They are 
necessary for maintenance of intercellular adhesion and regulation of paracellular 
transport being responsible to limit the access of microbes to host tissues and to 
mediate the antigenic traffic from the lumen to the lamina propria where they are 
processed, presented and eliminated (Roda G. et al, 2010).  
Impairment of the tight junctions seems to have higher impact in IBD 
pathogenesis (Clayburgh D. et al, 2004). Tight junctions consist of a complex 
structure composed by different proteins such as transmembrane proteins like 
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occludin and proteins of the claudin family and cytoplasmic peripheral membrane 
proteins like ZO (zonula occludens)-1,2 and 3 (Clayburgh D. et al, 2004). 
Recent studies have showed that elevated levels of proinflammatory cytokines, 
observed in IBD, induce expression alterations of some proteins like claudin and 
ocludin and reorganization of others what leads to an impairment of tight junctions 
and consequently loss of barrier function (Zeissig S. et al 2007; Mankertz J. et al, 
2000).  
 
Defensins  
 
Defensins are antimicrobial peptides produced by the intestinal mucosa that 
contribute to maintaining host immunity and protect from pathological flora. 
Defensins causes micropores in bacterial membranes what leads to the lost of 
pathogen integrity and consequent antimicrobial activity (Clayburgh D. et al, 2004). 
In IBD there is a deficiency in the defensin expression but if it is one of the 
causes or a consequence of the disease is yet to be known (Clayburgh D. et al, 
2004). 
 
Intestinal epithelial cells (IECs) 
 
Intestinal epithelial cells can be considered important immunoeffector cells with 
the capacity to release cytokines, chemokines, and other molecules involved in 
antigen presentation and immune defence.  
It is known that the innate immune system is able to recognize a limited set of 
conserved bacterial and viral motifs, pathogen-associated molecular patterns 
(PAMPs), through pattern recognition receptors (PPRs). The Toll-like receptor (TLR) 
and the nucleotide-binding oligomerization domain (NOD) are families of PPRs. IECs 
express several members of the TLR family (TLR 1,2,3,4,5) which recognize specific 
PAMPs and activate signal transduction through the NF-κβ pathway (Yamamoto-
Furusho J. et al , 2007). 
Recognition by TLRs protects against pathogens and is carefully regulated to shut 
down a proinflammatory response to comensal organisms. Alterations of TLRs 
expression and polymorphisms have been described in IBD causing amplification of 
inappropriated immune responses (Yamamoto-Furusho J. et al , 2007). 
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IEC also secrete proinflammatory cytokines like interleukin-6 and and in the last 
ten years research groups have discovered that they also secrete cytokines that 
regulate inflammation with chemoattractant proprieties for leukocytes and 
neutrophils (chemokines) and more recently have also shown that the cells also 
secrete chemokines for monocytes and lymphocytes (Stadnyk A. W.,2002). 
IECs are also involved in the antigen presentation activating subsets of T-cells 
with regulatory function and they cross talk with mucosal lymphocytes.  
 
In IBD during acute inflammatory episodes, the mucosal lining displays a 
characteristic inflammatory infiltrate of mast cells, lymphocytes, macrophages and 
activated neutrophils. Elevated levels of effector immune cells such as activated 
CD4+ and CD8+ cytotoxic T cells, cytolytic intraepithelial lymphocytes and perforin 
and granzyme-containing T-cells has been linked with damage of the epithelial gut 
mucosa in IBD (Neuman M. G., 2004) The figure below summarizes the alterations 
observed in IBD (fig.2).  
 
 
 
 
 
 
 
 
 	  
 
	  
 
 	  	  	  	  	  
Figure 2: The epithelial barrier 
system. A: Normal epithelial 
barrier; B: Inflammatory bowel 
disease (IBD) epithelial barrier. 
TLR: Toll-like receptors; MyD88: 
myeloid differentiation factor 88; 
TJ: Tight junctions (Roda G. et al, 
2010). 
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1.1.3 - IBD established and evolving therapies  
 
Nowadays, a specific causal treatment of IBD is still not available and the most 
currently drugs used in its treatment, particularly immunosuppressants and 
imunomodulators, are associated with significant side effects. The lack of 
effectiveness and the adverse effects of standard therapies have increased the need 
for the search of a new treatment that combines efficacy and safety. Patients often 
resort to the use of complementary and alternative medicines, particularly herbal 
therapies, with promising results (Rahimi R. et al, 2009). 
During the last years, dietary polyphenols have been a focus of intensive research 
mainly directed to its antioxidant activity in the context of prevention of oxidative 
stress-induced diseases. More recently, alternative pathways for their health-
promoting effects have been proposed, namely the modulation of signalling 
pathways in connection with physiological and pathophysiological conditions such as 
inflammatory processes.  
An important source of polyphenols is wine, particularly red wine. In the last years 
numerous studies described health-promoting effects of polyphenols such as 
antibacterial, antifungal, antiviral, antineoplastic, hepatoprotective, 
immunomodulating and anti-inflammatory proprieties, however fundamental aspects 
of molecular mechanisms underlying their protective role remain unknown. A clear 
understanding of the molecular mechanisms of action of polyphenols is crucial in the 
valuation of these potent molecules as potential prophylactic and therapeutic agents 
in IBD. 
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1.2 – Polyphenols 
 
1.2.1- Overview 
 
Polyphenols are present in a wide variety of fruits, vegetables and beverages like tea 
and wine. They have been regarded as antioxidants, preventing the deleterious 
effects of oxidants and free radicals but more recently they are also recognized as 
modulators of cell signaling and inflammation (Rahman I. et al, 2006, Laranjinha J. 
et al, 2010; Laranjinha J. et al, 2001 ). 
 
There are over 8000 structural variants of polyphenols but all these compounds 
have in common aromatic ring(s) bearing one or more hydroxyl moieties and its 
structure varies from simple molecules, like phenolic acids, to highly polymerized 
compounds, such as condensed tannins. They can be divided into at least 10 
different classes based upon their chemical structure (Bravo L., 1998), being 
flavonoids the most widely distributed group of plant polyphenols The most common 
structure of flavonoids is two aromatic rings linked through three carbons that 
usually form an oxygenated heterocycle (Rahman I. et al, 2006).  
In figure 3 the hydroxyl group in the B ring (R4’ replaced by a H atom) gives the 
polyphenol the capacity to participate in redox reactions by donating the H atom, 
yielding a stable o-semiquinone radical due to the charge delocalization between the 
aromatic rings, particularly when there is a double bond in the position 2:3 of ring C. 
 
 
 	  	  	  	  	  	  	  	  	  	  
Figure 3 -General structure and numbering pattern for common food flavonoids. For most 
food flavonoids, R4’=H, R5=OH and R6=H. Exceptions include, biochanin A, R4’=CH3; 
formononetin, R4’=CH3, R5=R6=H; glycitein, R5=H, R6=OH; and hesperitin, R4’=CH3. 
Additional individual flavonoids within each subclass are characterized by unique functional 
groups at R3, R3’, and R5’ (Beecher G., 2003). 
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1.2.2 – Naturally occurring polyphenols in wine 
 
Wine is an alcoholic beverage that contains a large amount of different 
polyphenols extracted from grapes during the process of vinification. In fact, red 
wine is one of the most abundant sources of polyphenols (Medic-Saric M. et al, 
2009). Phenolic compounds in grapes and wines belong to the following major 
classes: stilbenes, flavan-3-ols, flavonols, anthocyanins, hydroxybenzoic acids, 
procyanidins and hydroxycinnamic acids (Rodrigo R. et al, 2010) (table 1). The 
phenolic composition of the wine is not only dependent of the grape variety from 
which is made but also on some external factors such as climate and winemaking 
technology. 
 
Table 1- Wine polyphenolics chemical classification in decreasing content order (Rodrigo R. et 
al, 2010). 
 
Category 
 
Compound 
 
Flavonols 
 
Quercetin 
Myricetin 
Kaempferol 
Isorhamnetin 
Anthocyanins 
 
Cyanidin 
Malvidin 
Petunidin 
Delphindin 
Peonidin 
Pelargonidin 
Hydroxycinnamic acids 
 
Caffeic 
Ferulic 
p-coumaric 
Chlorogenic 
Hydroxybenzoic acids 
 
Gallic 
Ellagic 
Protocatechic 
Vanillic 
Syringic 
3,4-dihydrohybenzoic 
p-hydroxybenzoic 
Flavanols 
(+)-catechin 
(-)-epicathechin 
Stilbenes 
Resveratrol 
Piceid 
Procyanidins 
 Procyanidins A2, B1, B2, B3, B4 	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1.2.3- Absorption, bioavailability and metabolism of 
polyphenols 
 
The biological effects of polyphenols are of course dependent on their 
bioavailability that differs within each and every polyphenol. The chemical structure 
of the compound more than concentration determines the rate and extent of the 
absorption and the nature of the metabolites circulating in the plasma.  
Polyphenols are at least partially absorbed through the gut barrier and the 
quantities of polyphenols found intact in urine vary from one polyphenol to another 
(Scalbert A. et al, 2002). The polyphenol structure has a major impact on intestinal 
absorption.  
Most polyphenols are present in food in the form of esters, glycosides or polymers 
that cannot be absorbed in their native form. Therefore, before absorption they are 
hydrolysed by intestinal enzymes or by colonic microflora (Scalbert A. et al, 2002).  
Once absorbed polyphenols undergo extensive modification; they are conjugated 
by methylation, sulfation and/or glucuronidation (D’Archivio M. et al, 2007). Then the 
metabolites circulate in the blood bound to plasma proteins particularly albumin. 
Additionally, the bioavailability of polyphenols is reported to be low due to their low 
absorption and rapid elimination by urine and bile.  
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1.2.4- Polyphenols and cellular signaling 
 
In the last decades polyphenols have been the subject of an extensive research 
due to their observed biological effects in vitro such as free-radical scavenging, metal 
chelating properties and enzyme modulation abilities. 
Earlier studies on polyphenols have viewed these compounds only from the 
perspective of antioxidants, however many other effects of polyphenols such as anti-
inflammatory, anti-tumor, anti-atherogenic abilities could not be explained solely on 
the basis of their antioxidant properties. The extensive modifications that 
polyphenols undergo compromises their antioxidant properties but not their 
biological effects.  More recent investigations showed that polyphenols may not 
merely exert their effects as free radical scavengers but may also modulate cellular 
signaling processes or may themselves serve as signaling agents (Laranjinha J. et al, 
2010) 
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1.3- Polyphenols and inflammation 
 
1.3.1- Basic tenets of Inflammation 
 
Inflammation is a part of the nonspecific immune response that occurs in reaction 
to any type of bodily injury. It is a protective attempt by the organism to remove the 
injurious stimuli and to initiate the healing process.  
The defining clinical features of inflammation are redness, warmth, swelling and 
pain that can be explained by increased blood flow, elevated cellular metabolism, 
vasodilatation, release of soluble mediators, extravasation of fluids and cellular 
influx. 
Inflammation can be classified as either acute or chronic. In normal conditions 
inflammation is a self-limiting process but in some disorders the inflammatory 
process becomes continuous and consequently chronic inflammatory diseases 
develop. 
The two kinds of inflammation have very specific characteristics: acute 
inflammation is characterized by infiltration of innate immune system cells, 
specifically neutrophils and macrophages while infiltration of T lymphocytes and 
plasma cells are features of chronic inflammation (Ferrero-Milani L. et al, 2007). 
Monocytes/macrophages play a central role in both.  
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1.3.2- Molecular mechanisms of polyphenols as anti-
inflammatory agents 
 
 There is convincing epidemiological and experimental evidence that dietary 
polyphenols have anti-inflammatory activity (Middleton E. et al, 2000). The detailed 
and particular mechanisms by which each polyphenol induces an anti-inflammatory 
action remain to be elucidated. However it is now known that these natural 
compounds can work as modifiers of signal transduction pathways to elicit their 
beneficial effects exerting anti-inflammatory activity by modulation of pro-
inflammatory gene expression such as cyclooxygenase, lipoxygenase, nitric oxide 
synthases and several pivotal cytokines mainly by acting through nuclear factor-
kappa B (NF-­‐κB) and mitogen-activated protein kinase (MAPK) signalling (Santangelo 
C. et al, 2007).  
An additional explanation is that polyphenols can modulate the activity of redox 
pathways and its components in a cell during normal and pathophysiological 
conditions, particularly acting on Nrf 2 (Nuclear factor erythroid 2- related factor 2) 
(Rahman I. et al, 2006).  
It is important to note that the gastrointestinal tract is a compartment where the 
concentration of the dietary polyphenols might achieve its higher concentration in 
the body in an unmodified state and, therefore, where it might be expected 
polyphenol-dependent cellular modulatory processes via Nrf2, NF-κB and nitric oxide 
metabolism. 
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1.4- Nitric oxide 
	  
1.4.1- Nitric oxide: characteristics, chemistry and 
biosynthesis  
 
-Characteristics  	  
In the past few decades the interest and research about nitric oxide (●NO) have 
been growing. It was first discovered in the eighties when several groups of 
researchers were trying to identify the endothelium derived relaxing factor (EDRF) 
(Furchgott R. et al, 1980;  Ignarro et al, 1987; Palmer R. et al, 1987).  
Nowadays, ●NO is recognized as a versatile cellular modulator involved in a wide 
variety of physiological and pathological events such as immunitary response, 
vasodilation and neuromodulation. 
●NO is a peculiar radical species in many aspects, despite its extremely complex 
and diverse biological activity it is a simple molecule containing one nitrogen atom 
covalently bonded to an oxygen atom with one unpaired electron. It is one of the 
few gaseous signaling molecules and being a small hydrophobic molecule it can cross 
cell membranes without the help of channels or receptors as readily as molecular 
oxygen and carbon dioxide. ●NO is capable of penetrate rapidly across cell 
membranes and diffuses through considerable distances which means that it can 
affect a great number of biological processes.  
 
-The chemistry of ●NO  
 
●NO has a very rich chemistry, despite not being a highly reactive compound it 
can react with several chemical species. To better understand its complex chemistry 
we can divide the effects that involve ●NO in direct and indirect (figure 4).  
Direct effects results from direct reactions between ●NO and specific biological 
molecules (metal centers and radical species). These effects predominate at lower 
concentrations. 
The reactions between ●NO and metal complexes can be classified in three types: 
(1) the direct reaction of ●NO with a metal center, (2) ●NO redox reaction with 
dioxygen metal complexes and (3) reduction of oxo-metalic complexes (Wink D. and 
Mitchell J., 1998). The reactions of NO with heme-iron containing proteins are the 
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most physiologically relevant and include the reaction with soluble guanylate cyclase 
(sGC) (Frieb A. et al, 2003), which plays an important role in neuromodulation and 
vasodilation.  
●NO can also react with other radical species like carbon-centered radicals, lipid 
radicals and nitrogen dioxide (Wink D. and Mitchell J., 1998). 
The indirect effects are defined as those resulting from the reactions of RNS, 
derived from ●NO, with various biological targets. These effects predominate at 
higher concentrations and usually result in nitroxidative stress. Usually, this involves 
the reaction of ●NO oxygen or with the superoxide radical (O2●−) ultimately forming 
products that are responsible for nitrative and nitroxidative stress with toxic effects 
in the cells.  
In fact, most of the deleterious effects assigned to ●NO are supported  by its 
reaction with O2●− to produce peroxynitrite (ONOO
-
) in a diffusion-controlled reaction 
(k=1.9x1010 M-1s-1). ONOO
-
 acts as a powerful oxidant and nitrating agent modifying 
proteins, lipids and nucleic acids. 
One important modification of proteins induced by ONOO
-
 is the formation of 
nitrotyrosine. The nitration of protein tyrosine residues to 3-nitrotyrosine is one of 
the molecular footprints left by the reactions of RNS with biomolecules (Radi R., 
2004). This post-translational modification can alter protein function and it´s being 
associated with acute and chronic diseases and can be a predictor of disease risk 
(Radi R., 2004). Despite the existence of repair mechanisms and the presence of in 
vivo reductants like GSH and the small fraction of nitrated proteins when compared 
to the total tissue protein, nitration can be focused on specific tyrosines resulting in 
modifications, encompassing loss or gain of protein function (Radi R., 2004). One 
example of the biological significance of protein tyrosine nitration is the loss of 
enzyme activity of the manganese superoxide dismutase (MnSOD) when nitrated by 
peroxynitrite in Tyr-34. Nitrated and inactivated MnSOD is found in both acute and 
chronic inflammatory processes (MacMillan-Crow L. et al, 1996). 
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Figure 4- Chemical biology of nitric oxide: direct and indirect effects. Adapted from Wink D. 
and Mitchlell J., 2001.  
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-●NO Biosynthesis 
 
The biosynthesis of nitric oxide can occur in two different ways: enzymatic and 
non-enzymatic. 
 Nitric oxide synthase (NOS) had been considerate the primary source of ●NO in 
biological systems but there is also the contribution of enzyme-independent ●NO 
generation. 
 
Enzymatic ●NO biosynthesis 
 
Three distinct isoforms of NOS have been identified: inducible NOS (iNOS), 
endothelial NOS (eNOS) and neuronal NOS (nNOS). They are products of three 
distinct genes with different localization, regulation, catalytic proprieties and inhibitor 
sensitivity (Alderton W. et al, 2001). eNOS and nNOS are constitutively expressed 
and their activities are regulated by intracellular calcium concentrations via 
calmodulin. The function of iNOS is not affected by intracellular calcium 
concentrations because iNOS is bound to calmodulin even under resting intracellular 
calcium concentration. While eNOS and nNOS produce low fluxes of ●NO for short 
periods of time, iNOS produces higher ●NO levels for long periods of time. 
 
Structure of the NOS 
In their active form NOS are dimeric and each monomer is associated with a 
calmodulin (CaM), they also contain relatively tightly-bound cofactors like (6R)-
5,6,7,8-tetrahydrobiopterin (BH4), FAD, FMN and iron protoporphyrin IX (haem) 
(Alderton W. et al, 2001). 
The NOS structure can be divided in two distinct domains: oxygenase domain and 
reductase domain. 
The N-terminal oxygenase domain contains biding sites for haem, BH4 and L-
arginine and it’s linked by a CAM-recognition site to a C-terminal reductase domain 
that has binding sites for FAD, FMN and NADPH (Alderton W. et al, 2001).  
 
Reactions catalysed by NOS 
The synthesis of ●NO requires L-arginine, NADPH and oxygen as substrates and 
the presence of other coenzymes/cofactors, as well as the presence of CaM. 
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Citrulline, NADP and ●NO are the products of the overall reaction (Knowles R. et al, 
1994). 
In this reaction electrons are donated by NADPH to the reductase domain of the 
enzyme and proceed via FAD and FMN redox carriers to the oxygenase domain. In 
this domain they interact with the haem iron and BH4 at the active site to catalyse 
the reaction of oxygen with L-arginine, generating citrulline and ●NO as products. 
The electron flow through the reductase domain requires the presence of bound 
Ca2+/CaM (figure 5).  
 
 
 
 
 
 
 
 
 
 
Figure 5-Overall reaction catalysed and cofactors of NOS (Alderton W. 2001). 
 
Regulation of NOS 
NOSs are probably one of the more regulated enzymes in nature. Due to the wide 
variety of physiological roles of these enzymes regulation is complex. Activity, 
expression and localization are regulated by protein-protein interactions, alternative 
mRNA splicing and covalent modifications (Alderton W. et al, 2001). 
The regulation of NOS activity is done by CaM, calcium, phosphorylation, protein 
inhibitor of NOS (PIN) and heat-shock protein 90 (Hsp90).  
 
 
Table 2- Regulation of NOS (adapted from Alderton W. et al, 2001 ). 
 
 
  
Type of regulation 
 
nNOS eNOS iNOS 
Alternate mRNA splicing Yes Not reported Yes 
Protein-protein 
interactions 
CaM/Ca2+, PDZ 
domains, PIN, caveolin-
1, Hsp90 
CaM/Ca2+, caveolin-1 
and -3, Hsp90, ENAP-1 
CaM/Ca2+, kalirin 
Covalent modifications Phosphorylation Myristoylation, 
palmitoylation, 
phosphorylation 
Not yet reported 
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Non-enzymatic ●NO biosynthesis 
 
A few years ago the inorganic anions nitrate (NO3 -) and nitrite (NO2 -) were 
thought to be inert and products of endogenous nitric oxide metabolism. However it 
is now known that they can be an alternative source of ●NO to the classical L-
arginine- ●NO - synthase pathway particularly in hypoxic states (Lundberg J. et al, 
2008).	  
Nitrate is present in several dietary sources like green leafy vegetables (lettuce, 
spinach) and nitrite appears majorly in cured meat and cereals, but the major source 
of nitrite is the reduction of nitrate in the oral cavity by commensal bacteria 
(Lundberg J. et al, 2008).	  
Under highly acidic conditions, which occur in the stomach, nitrite yields ●NO and 
other reactive nitrogen species (Zweir J. et al, 1999). 	  	  
This equilibrium can be represented by the following reactions:	  
NO2– + H+ ⇆ HNO2      (1) 
2HNO2⇆•NO +•NO2 + H2O    (2) 
•NO + •NO2 ⇆ N2O3-    (3) 
 
 	  
●NO will leave the aqueous phase of the stomach being present in the expelled 
air. Measurements of ●NO in the expelled air can be used as a non-invasive method 
for estimation of gastric acidity (Lundberg J. et al, 1994).	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1.4.2- ●NO and inflammation 
	  
●NO is called a “double-edge-sword” or “Jekyll and Hide” because it can trigger 
pro- or anti-inflammatory effects. The apparent inconsistence could be explained by 
the multiple cellular actions of this molecule and the level and site of ●NO production. 
Products based in ●NO and not ●NO directly are responsible for the opposite effects.  
 
- Anti-inflammatory effects 	  
In small amounts ●NO have been shown to exert anti-inflammatory activities. 
Several studies demonstrate that this molecule confers anti-adhesive proprieties to 
the endothelium inhibiting the adhesion of leucocytes (Kubes P. et al, 1991), 
decrease P-selectin expression by platelets, platelet adhesion, aggregation and 
microvascular thrombosis, reduce mast cell degranulation, lymphocyte proliferation 
and oxidant production by phagocytes and also can down-regulate macrophage 
cytokine production. All this effects reduce the inflammatory response and inhibit its 
progression (Clancy R.et al, 1998). 
 
- Pro-inflammatory effects 	  
An excessive inflammatory cytokine production is responsible for the induction of 
iNOS, which produces large amounts of ●NO (Clancy R. et al, 1998). An increased 
production of ●NO has been implicated in diseases such as sepsis (Petros A. et al, 
1991) and ulcerative colitis (Middleton S. et al, 1993). For that reason increased ●NO 
overproduction is a reflection of an immune-activated state in which inflammatory 
cytokines and other mediators have up-regulated iNOS in diverse tissues. 
Large amounts of ●NO produced by cells in response to cytokines can destroy host 
tissues and impair cellular responses. The indirect effects of ●NO, described 
previously, are specially implicated in these pro-inflammatory effects: the formation 
of reactive nitrogen species such as peroxynitrite triggers toxic events that culminate 
in citotoxicity and nitration and nitrosation of several residues in diverse 
proteins,affecting their function (ex. iron-sulfur containing enzymes, disruption of 
mitochondrial respiration) (Clancy R. et al, 1998).  
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1.4.3 - ●NO in the gastrointestinal tract 
 
Besides the cellular effects in the inflammation this radical also have tissue effects 
in the gastrointestinal tract. ●NO has an effect on gastrointestinal secretion, 
permeability and blood flow (Lanas A., 2008). 
Mucus and epithelial cell fluid contribute to gastrointestinal defense by acting as a 
physical barrier to damage caused by microbes, toxins and irritants and contributing 
to the protection of the epithelium from damage caused by acid and pepsin.  The 
production of these fluids is enhanced by ●NO (Sharma J. et al, 2007). 
●NO , acting as a vasodilator, actuate in the microcirculation increasing mucosal 
blood flow. This fact results in the buffering of acid, dilution of toxins and stimulation 
of angiogenesis, all this effects are critical in mucosal protection (Bjorne H. et al, 
2004). 
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1.5 - Nuclear factor-kappa B (NF-κB) 
 
1.5.1- Overview 
 
NF-­‐κB is a pleiotropic transcription factor that plays a critical role in diverse 
cellular processes associated with proliferation, cell death, inflammation, as well as 
innate and adaptative immune responses. The NF-­‐κB signalling pathway has been 
implicated in the pathogenesis of several inflammatory diseases including IBD 
(Rogler G. et al, 1998). It was first identified twenty years ago regulator of 
expression of the κΒ light chain in B cells and target of vast research ever since.  
In mammals the NF-­‐κB family is constituted by five members, these include p65 
(also called RelA), c-Rel, RelB, p50 and p52. These subunits only exist as homo or 
heterodimers in resting cells and all of them have a Rel homology domain (RHD) 
containing a nuclear localization sequence (NLS) involved in dimerization, sequence-
specific DNA binding and interaction with the inhibitory IκB proteins (Hayden M. et 
al, 2008).  
A large number of physiological stimuli are known to activate NF-­‐κB (e.g. bacterial 
and viral products, pro-inflammatory cytokines, cellular receptors and ligands), which 
in turn activates an equally large number of target genes (e.g. chemokines, immune 
receptors, adhesion molecules).  
 
1.5.2- Cascade and key molecules 
 
In resting conditions the majority of NF-­‐κB dimers are maintained in a latent 
cytoplasmic form through binding to a member of the inhibitor of NF-­‐κB (IκB) 
protein family (Verma I. et al, 1995), which includes IκBα, IκBβ, IκBε, the p100 and 
p105 precursor proteins and the atypical members Bcl-3, IκBNS and IκBς.  
The rate-limiting step in the activation of the NF-­‐κB pathway is the release of the 
DNA binding subunits from de IκB proteins that act as chaperones sequestering the 
NF-­‐κB into the cytoplasm. After receiving relevant stimulation that activates NF-­‐κB, 
the IκB proteins are degraded and NF-­‐κB is translocated to the nucleus where it acts 
as a transcription factor by binding to regulatory DNA sequences known as κB sites 
(Wan F. et al, 2010).  
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Currently there are three distinct ways by which stimuli lead to generation of free 
NF-­‐κB and NF-­‐κB dependent transcription: the canonical, non-canonical and the 
atypical NF-­‐κB activation pathways. The majority of inducers of NF-­‐κB are known to 
operate via the canonical mechanism, the non canonical is crucial for lymphoid 
organogenesis and activated by very few inducers and the atypical mechanism is 
described as a response to DNA damage by agents that cause lesions in DNA such 
UV radiation and doxorubicin (Wan F. et al, 2010). 
 
-The canonical pathway 
 
Being activated by proinflammatory signals such as cytokines, pathogen-
associated molecular patterns (PAMPs) and some danger-associated molecular 
patterns (DAMPs) the canonical pathways is particularly interesting in inflammatory 
conditions such as IBD. This signals work through different receptors belonging to 
the tumor necrosis factor (TNF) receptor (TNFR) and Toll-like receptor (TLR)-
interleukin-1(IL-1) receptor (IL-1R) superfamilies (Shih V. et al, 2011) . 
Upon receiving relevant stimulation that warrants activation of NF-κB, the IκB 
kinase (IKK) complex is activated by upstream kinases, like NIK, MEKK-1 and RIP 
through phosphorylation of specific serine residues in the activation domain of each 
IKK subunits. The IKK complex contains at least two kinases subunits (IKK1 and 
IKK2) and a non-catalytical associated modulator (called IKKγ ,NEMO or IKKAP) 
(Karin M., 1999). 
The canonical pathway is defined as being mediated by a NEMO-dependent IKK, 
in contrast with the noncanonical which doesn´t requires NEMO. 
Then the activated IKK complex phosphorylates IkB proteins on specific serine 
residues, triggering their ubiquitination and proteosomal degradation, which allows 
NF-kB translocation to the nucleus and activation of gene transcription (Wan F. et al, 
2010) (figure 6).  
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Figure 6 - NF-­‐κB Signaling pathways (canonical pathway) (Hayden M. et al, 2004). 
 
1.5.3- NF-kB target genes 
 
NF-­‐B dimers bind to a set of related10 bp DNA sites, collectively called κB sites, to 
regulate the expression of many genes. The major classes of NF-­‐κB target genes are 
cytokines and chemokines, immune receptors, adhesion molecules, stress response 
genes, regulators of apoptosis, transcription factors, growth factors, enzymes (e.g. 
collagenase and lysozyme) and cell cycle regulators (Pahl H., 1999). 
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1.6 - Nuclear factor erythroid 2- related factor 2 
(Nrf2) 
 
1.6.1- Overview 
 
Nrf2 was originally identified in 1994 during a screen for proteins that bind to the 
control region of the β- globin gene (Moi P. et al, 1994).   
This transcription factor is ubiquitously expressed in a wide range of cell types 
and tissues including liver, lung, intestine and kidney  (Moi P. et al, 1994).  It is part 
of the cap ‘n’ collar family of transcriptions factors that share a highly conserved 
basic region-leucine zipper (bZIP) structure (Moi P. et al, 1994) (figure 7). 
The basic region upstream the leucine zipper is responsible for the DNA binding 
(Jaiswal A., 2004) and the acidic region is required for transcriptional activation. 
ARE-mediated transcriptional activation involves heterodimerization of Nrf2 with 
other bZIP proteins such as Jun and small Maf (Itoh K. et al, 1997; Venugopal R. et 
al, 1998). 
 The Nrf2 binding site is a subset of the antioxidant response elements (ARE), 
ARE’s are regulatory sequences found on promotors of several detoxification genes.  
This transcription factor mediates a broad-based set of adaptive responses to 
intrinsic and extrinsic cellular stress.  
 
1.6.2-Negative regulation of Nrf2 by Keap1 
 
A cytosolic inhibitor of Nrf2 was identified in 1998 and named Keap1 (Kelch-like 
ECH-associated protein 1) (Itoh K. et al, 1999) (figure 7).   
Keap1 has two discrete structural domains. One is the double glycine repeat 
(DGR) moiety (also known as the Kelch motif), and the other is the BTB protein 
interaction domain. The DGR region binds to the Nrf2- ECH homology 2 (Neh) 
domain of the N-terminal portion of Nrf2 whereas the other portion binds with the 
actin cytoskeleton causing Nrf2 sequestration in the cytoplasm and repression of his 
activity (Itoh K. et al, 1999). Keap1 also has three additional domains: the N-terminal 
region, the intervening region that is an especially cysteine-rich region and the C-
terminal region (Jaiswal A., 2004).  
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Keap1 releases Nrf2 from sequestration during periods of oxidative stress or 
following exposure to electrophiles, The alliance between Keap1 and Nrf2 seems to 
function as a cellular redox sensor through which the activation of ARE-dependent 
genes in response to oxidative stress is regulated (Itoh K. et al, 1999). Keap1 
releases Nrf2 from sequestration during periods of oxidative stress or following 
exposure to electrophiles and after dissociation, Nrf2 translocates to the nucleus 
allowing gene transcription.  
 
 	  	  	  	  	  	  	  	  	  	  	  	  
Fig. 7- Schematic presentation of various domains of Nrf2 and Keap1: NTR,N-terminal region; 
BTB,broad complex tramtrack bric-a-brac; IVR, intervening/linker region; DGR, Kelch 
domain/diglycine repeats; CTR, C-terminal region. (adapted from Kaspar J. et al, 2009) 
 
-Dissociation 
 
Multiple steps appear to be important in triggering the dissociation of Nrf2 from 
Keap1.  These events include modification of critical cysteine residues within Keap1 
and phosphorylation of Nrf2. 
Modification of Keap1 cysteines by ARE inducers is postulated to directly cause 
dissociation of the Keap1–Neh2 interaction, leading to Nrf2 nuclear accumulation. 
Dinkova-Kostova (Dinkova-Kostova A. et al, 2002) and Wakabayashi (Wakabayashi 
A. et al, 2004) studies have established the widely accepted model that electrophilic 
modification of Keap1 leads directly to dissociation of the Keap1–Nrf2 complex. 
However these studies have been performed using the murine Keap1 – Nrf2 system, 
in humans the direct disruption model is invalid, and the most reactive cysteines of 
human Keap1 are not the same as those reported for mouse Keap1 (Eggler A. et al, 
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2005). Eggler study supports a model whereby electrophilic modification of Keap1 
alone does not disrupt the Keap1–Nrf2 complex (Eggler A. et al, 2005).  
Although somewhat controversial, accumulating evidence suggests that 
phosphorylation of Nrf2 is also important for dissociation of Nrf2 from Keap 1. 
Multiple kinases (ex. MAP kinases) can phosphorylate Nrf2 and alter transcription of 
Nrf2 (Yu R. et al, 2000; Zipper L. et al 2000), however phosphorylation of Nrf2 by 
some protein kinases (ex. protein kinase C (Bloom D. et al, 2003)) does not alter 
transcription but only the dissociation process. Further research is yet required to 
elucidate the mechanistic details of the electrophilic signal transduction mechanism 
of Nrf2 nuclear accumulation. 
 
-Ubiquitination 
 
Nrf2 has a short half-life, approximately 13-20 minutes, due to constitutive 
ubiquitin-proteosomal degradation (McMahon M. et al, 2003; Nguyen T. et al, 2003). 
Keap1 function as an adaptor protein in an ubiquitin-proteosome complex named 
Cul3-based E3 ligase complex. Keap1-Cul3 complexes act as Nrf2-specific E3 
ubiquitin ligases that direct Nrf2 for polyubiquitination and destruction via 
proteasome (Cullinan S. et al, 2004). 
For that reason Keap1 is responsible not only for sequestering Nrf2 but also for its 
normal proteasomal targeting and degradation. 
 
1.6.3 - Other regulatory mediators of Nrf 2 
	  
Apart from Keap1 there are other negative regulatory mediators of Nrf2 namely 
Bach 1 (BTB and CNC homology 1, basic leucine zipper transcription factor 1) and 
GSK3β/Fyn. They are very important in repressing Nrf2 downstream genes that are 
induced in response to oxidative/electrophilic stress.  
Bach 1 is a transcription repressor that belongs to the cap'n'collar type of basic 
region leucine zipper factor family (CNC-bZip) (Oyake T. et al, 1996), ubiquitously 
expressed in tissues and distant related to Nrf2.  
Bach 1 forms heterodimers with small Maf (Oyake T. et al, 1996) proteins that 
bind to the ARE (Dhakshinamoorthy S. et al, 2005) repressing gene expression.  
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Bach 1 competes with Nrf2 for binding to the ARE, which leads to the suppression of 
Nrf2 downstream genes (Dhakshinamoorthy S. et al, 2005).  
Nuclear import of Nrf2 is followed by activation of a delayed mechanism involving 
glycogen synthase kinase 3β (GSK3β), a multifunctional serine/threonine kinase, 
which controls the switching off of Nrf2 activation of gene expression. This enzyme 
phosphorylates Fyn at threonine residue(s), phosphorylated Fyn accumulates in the 
nucleus and phosphorylates Nrf2 at tyrosine 568 leading to nuclear export, 
ubiquitination, and degradation of Nrf2 (Jain A. et al, 2006; Jain A. et al, 2007). 
 
1.6.4 - Molecular mechanisms underlying Nrf2 – mediated 
transcription 
 
Into the nucleus Nrf2 can form heterodimers with a variety of transcriptional 
regulatory proteins, the complexes bind to motifs known as antioxidant or 
electrophile response elements (ARE/EpRE) located in the promoter or upstream 
promoter regions of detoxification genes.  
The partners of Nrf2 are commonly members of the activator protein-1 (AP-1) 
family such as Jun and Fos (Venugopal R. et al, 1998) or the small Maf family of 
transcriptional factors (Itoh K. et al, 1997). Jun and Fos bind ARE sequences acting 
as positive and negative regulators, respectively, of ARE gene transcription.  The 
precise role of small Maf proteins in the transactivation of ARE-containing genes 
remains yet controversial. Summarizing we can say that the Nrf2 driven transcription 
is influenced negatively or positively by the identity of the heterodimer partner. 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure.8- Regulation of Nrf2-mediated transcription 
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1.6.5 - Nrf2 regulated genes 
 
The gene families affected by Nrf2, ARE-containing genes, have several 
cytoprotective actions: they can provide direct antioxidants, encode enzymes that 
directly inactivate oxidants, increase levels of glutathione synthesis and regeneration, 
stimulate NADPH synthesis, enhance toxin export through the multidrug-response 
transporters, enhance the recognition, repair, and removal of damaged proteins, 
elevate nucleotide excision repair, regulate expression of other transcription factors, 
growth factors and receptors, and molecular chaperones and inhibit cytokine-
mediated inflammation (Wakabayashi N. et al, 2010). 
 
Table 3 – Examples of Nrf2-responsive genes. Adapted from Aleksunes and Manautou 
(Aleksunes L. et al, 2007) 
 
Cellular Process Nrf2-related genes Function 
Glutathione 
Homeostasis 
Glutamate-cysteine ligase 
(Gcl) 
Catalyze formation of Υ-
glutamylcysteine 
Glutathione synthetase (GS) Catalyze addition of glycine 
to Υ-glutamylcysteine 
Glutathione-S-transferase 
(Gst) 
Conjugate glutathione to 
chemicals 
Glutathione peroxidase –
gastrointestinal (GI-GPx) 
Reduce hydrogen 
peroxidase and alkyl 
hydroperoxides 
Drug metabolism NAD(P)H quinone 
oxidoreductase 1 (Nqo1) 
Reduce quinones and 
endogenous antioxidants, 
scavenge superoxide 
UDP-glucuronosyltransferase 
(Ugt) 
Catalyze addition of 
glucuronic acid to chemicals 
Microsomal epoxide 
hydrolase (mEH) 
Hydrolyze epoxides 
Stress Response Heme oxygenase (Ho-1) Catabolize heme to carbon 
monoxide, biliverdin and 
free iron 
Iron metabolism Ferritin Sequester free iron 
Excretion/Transporters Multidrug resistance-
associated proteins (Mrp) 
Efflux chemicals across cell 
membrane 
Multidrug resistance proteins 
(Mdr) 
Efflux chemicals across cell 
membrane 	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1.6.6 - Nrf2 interactions with additional pathways 
 
Like other signalling pathways the Keap1-Nrf2 pathway does not function isolated, 
some of the protective effects may be mediated indirectly through cross talk with 
additional pathways affecting the cell fate (figure 9). Recent evidences suggest the 
existence of transcriptional cross-talk between Nrf2 and the arylhydrocarbon 
receptor, NF-­‐κB , p53 and Notch pathways (Wakabayashi N. et al, 2010).  
The cross talk between Nrf2 and NF-­‐κB is an area of extensive research. The NF-­‐
κB pathway is involved in several processes such as inflammation, immune response, 
apoptosis and cell growth. Targets of NF-­‐κB include genes classified as chemokines, 
cytokines, immunoreceptors, cell-adhesion molecules, stress-response genes, and 
regulators of apoptosis among many others. NF-­‐κB was recently shown to prevent 
the transcription of Nrf2 dependent genes by reducing the availability of co-activator 
levels and promoting recruitment of a co-repressor (Liu G.H. et al, 2008).  
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 
Fig.9- Possible means for regulation of cell survival and other cell-fate responses through 
interactions of Nrf2 with additional cell-signaling pathways, including AhR, NF-­‐κB, p53, and 
Notch1. Adapted from Wakabayashi N. et al, 2010. 
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Objectives  
 
Considering that polyphenols are strong antioxidants but are also known to 
interfere in inflammatory signalling pathways and, on the other hand, Nrf2, NF-­‐κB 
and •NO metabolism are potential targets for polyphenols and regulators of 
inflammatory processes, our main goal is to investigate the potential anti-
inflammatory effect of a red wine polyphenolic extract (RWE) against gastrointestinal 
inflammation by using cultured intestinal cell models. This is of biological significance 
for the prevention of chronic inflammation such as the inflammatory bowel disease. 
Confirmation of this hypothesis will provide new directions in the development of 
prevention and new treatments for reducing the extent of gastrointestinal 
inflammation.  
Specifically, we propose to:  -­‐ Evaluate the potential anti-inflammatory effect of a RWE in HT-29 cells 
screening inflammatory parameters  (activation of NF-­‐κB, IL-8 production, 
iNOS induction and ●NO production).  -­‐ Evaluate if RWE could have other protective effects, including the protection 
against tyrosine nitration and modification of the occludin distribution in HT-
29 cells stimulated with cytokines. -­‐ Investigate if RWE could activate the Nrf2 pathway in HT-29 cells and if that 
could be the molecular mechanism involved in their anti-inflammatory action. 
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Chapter 2: Materials and Methods  
 
 
2.1- Materials 
	  
HT-29 cell line was purchased from Sigma-Aldrich (St Louis, MO, USA). Red wine 
extracts were obtained by Prof. Dr. Vítor Freitas (Chemistry Department, Faculty of 
Science, University of Porto, Porto, Portugal) (see annex 1 for detaied composition), 
DMEM- Modified Eagle Medium with Glutamax (GlutamaxTM), foetal bovine serum 
and trypsin were purchased from Gibco (Grand Island, NY, USA). The enzyme-linked 
immunosorbent assay (Quantikine Immunoassay for Human IL-8) was obtained from 
R&D Systems (Minneapolis, MN, USA). Secondary monoclonal antibodies (anti-
mouse, anti-rabbit, anti-goat) conjugated with alkaline phosphatase were purchased 
from abcam (Cambridge, CB, UK), primary monoclonal antibody anti-iNOS was 
purchased from Santa Cruz (Santa Cruz, CA, USA), primary monoclonal antibody 
anti-IκB was obtained from Cell signaling,primary monoclonal antibody anti-Nrf2 was 
obtained from R&D Systems (Minneapolis, MN, USA) and primary monoclonal 
antibody anti-actin was purchased from Sigma-Aldrich (St Louis, MO, USA). Alexa 
Fluor anti-mouse and anti-rabbit IgG were obtained from Invitrogen (Carlsbad, CA, 
USA). Polyvinylidene difluoride membranes and ECF substrate were purchased from 
Amersham/GE Healthcare (Buckinghamshire, BKM, UK). All other chemicals were 
obtained from Sigma-Aldrich (St Louis, MO, USA) with the highest purity available. 
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2.2-Methods 
 
2.2.1- Cell Culture 
 
HT-29 cells are an epithelial cell line derived from human colonic adenocarcinoma 
that is able to express differentiation features characteristic of mature intestinal cells. 
Cell cultures were grown in DMEM medium without antibiotics supplemented with 
foetal bovine serum (10% vol/vol) onto 75 cm2 flasks and maintained at 37ºC, in a 
humidified atmosphere of 5% CO2. Twenty-four hours before any experiment cells 
were deprived meaning that they were washed with phosphate-buffered saline (PBS) 
and cultured in fresh medium without foetal bovine serum.  
 
2.2.2- Analysis of cell viability 
 
Cell viability was assessed using the MTT assay. The MTT assay is a colorimetric 
assay based on the reduction of the yellow dye MTT (3-(4,5 dimethylthiozol-2-yl)-
2,5-diphenyl-tetrazolium bromide) to formazan, an insoluble intracellular blue 
product, by cellular dehydrogenases (Denizot F., and R. Lang. 1986).  
In this assay cells were cultured in 24 wells plates under specific conditions, after 
that the medium was removed and cells were washed twice with PBS. Then MTT was 
added to each well (final concentration of 0,5 mg/ml) and culture plates were 
incubated for 1h at 37ºC. After the incubation, MTT was removed and 1 ml of DMSO 
was added and mixed until the formazan crystals dissolve. The extent of MTT 
reduction was measured spectrofotometrically at 540 nm in a plate reader.	   
 
2.2.3- Interleukin-8 (IL-8) analysis 	  
Levels of IL-8 protein secreted to the medium by the HT-29 cells were determined 
by enzyme-linked immunosorbent assay (ELISA) following the manufacturer´s 
instructions.  
In this assay a monoclonal antibody against IL-8 was pre-coated onto a 
microplate, then standards and samples were added to the wells and any IL-8 
present bound to the immobilized antibody. After washing away any unbound 
substance an enzyme-linked polyclonal antibody specific for IL-8 was added to the 
wells and another wash to remove any unbound antibody-enzyme reagent was 
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preformed. Afterwards a substrate solution was added to the wells and colour 
develops in proportion to the amount of IL-8 bound in the initial step. Color 
development is then stopped and the intensity of the colour was measured at 450 
nm.  
 
2.2.4- Preparation of whole cell, cytoplasmic and nuclear 
lysates 	  
To the preparation of whole cell lysates after the incubation under the specified 
conditions, the cells into the plates were washed twice with PBS, ressuspended in ice 
cold lysis buffer [50 mM Hepes pH 7.4, 150 mM NaCl, 2 mM EDTA, 10% (w/v) 
glycerol, 0.5% (w/v) sodium deoxycholate, 1% (v/v) Triton X-100, 1mM NaVO4, 
5mM NaF, 1 mM PMSF, 1/100 (v/v) proteases cocktail inhibitor] and maintained in 
ice for 15 minutes. Lysates were then centrifuged at 14 000 rpm for 10 minutes at 
4°C and supernatants were subsequently collected and stored at −80°C.  
To the preparation of cytoplasmic lysates cells were also washed twice with PBS, 
ressuspended in ice cold cytoplasmic extracts buffer [10mM Tris-HCl pH 7.5, 10 mM 
NaCl, 3mM MgCl2, 0,5%(v/v) Igepal, 1mM NaVO4, 5mM NaF, 1 mM PMSF, 1/100 
(v/v) proteases cocktail inhibitor], maintained in ice for 5 minutes and centrifuged at 
5 000 rpm for 5 minutes at 4ºC and supernatants were subsequently collected. To 
the preparation of nuclear lysates the pellet obtained in the last step was 
ressuspended in ice cold nuclear extracts buffer [20 mM Hepes pH 7.5, 300 mM 
NaCl, 5mM MgCl2, 0,2 mM EDTA, 1 mM DTT, 20%(v/v) glycerol, 1mM NaVO4, 5mM 
NaF, 1 mM PMSF, 1/100 (v/v) proteases cocktail inhibitor], maintained in ice for 5 
minutes and centrifuged at 14 000 rpm for 20 minutes at 4ºC and supernatants were 
subsequently collected. Cytoplasmic and nuclear lysates were stored at -80ºC.   
 
2.2.5- Protein determination 
 
The protein content of the extracts was determined by the Bio-Rad protein assay 
dye, using bovine serum albumin as the standard. This assay is based on the colour 
change of Coomassie Brilliant Blue G-250 dye in response to various concentrations 
of protein (Bradford dye-binding procedure) (Bradford M., 1976). 
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2.2.6- Western Blot 
 
Equal amount of protein present in the lysates were analysed by Western blot. 
Proteins were first denatured and then separated by SDS-PAGE (sodium dodecyl 
sulphate polyacrylamide gel electrophoresis) at 150V The separated proteins were 
electrotransferred to a polyvinylidene difluoride (PVDF) membrane for 2 h at 200 
mA. To avoid non-specific binding, membranes were blocked for 1 h at room 
temperature with 5% (w/v) non-fat dried milk in TBS-T buffer [25 mM Tris–HCl pH 
7.6, 150 mM NaCl, 0.1% (v/v) Tween 20].  
Membranes were then incubated overnight at 4°C with primary monoclonal 
antibody (dilution 1:1 000) (anti-actin, anti-iNOS, anti-IκB, anti-Nrf2). After six 
washes of ten minutes with TBS-T, membranes were incubated with phosphatase 
alkaline-labelled secondary antibody (dilution 1:20 000) for 1.5 h at room 
temperature. Membranes were washed again six times with TBS-T. The bands were 
revealed with ECF and visualized in a Typhoon system. The images were analysed 
with the Quantity One software (BioRad). Β-actin was used as a loading control.   
 
2.2.7- Nitric Oxide production determination 
 
In aqueous solution, nitric oxide rapidly degrades to nitrite, which accumulates in 
the medium. Nitrite in the cell culture supernatants is reduced by an iodide/tri-iodide 
containing reaction mixture to nitric oxide, which is released into the gas phase.  
Then NO was measured by chemiluminescence. By this method NO reacts with 
ozone (O3)to produce nitrogen dioxide in excited state (NO2*) which returns to the 
ground state emitting light (hv). Light emission is linearly related to the NO content 
of the sample.  
•NO + O3 → NO*2+ O2 + hv 
 
Gas phase chemiluminescence is highly sensitive to quantify •NO and nitrosated 
compounds in biological samples with low levels of these species.  
The reaction mixture (45 mmol/L potassium iodide (KI) and 10 mmol/L iodine (I2) 
in glacial acetic acid) was kept at 56ºC in a septum-sealed reaction vessel, 
continuously bubbled with nitrogen. The outlet of the gas stream was passed 
through a scrubbing bottle containing sodium hydroxide (1 mol/L; 0°C) in order to 
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trap traces of acid and iodine before transfer into the detector (CLD 88 Eco Medics, 
Switzerland). 
 Sodium nitrite standards and sample aliquots (100 µL) are injected into the 
reaction mixture by Hamilton syringes. •NO signal output was sampled at 2 Hz. Peak 
integration is performed using the EDAQ Power Chrom software.  
 
2.2.8- Immunohistochemistry  
 
HT-29 cells were cultured in twenty-four wells plates onto glass coverslips. After 
incubation under their specified conditions, the cells were washed with PBS, fixed 
with 4% (w/v) paraformaldehyde in PBS during ten minutes and stored if needed at 
4ºC with PBS into the well. Permeabilization and blockage were made incubating the 
glass coverslips into de plates with PBS containing 0,1% of saponin and 5% of fetal 
bovine serum during 30 minutes. Subsequently, cells were incubated with the 
primary antibody, washed twice with PBS for 5 minutes and then incubated with the 
appropriated fluorescent secondary antibody. After another two washes, the glass 
coverslips were mounted in microscope slides using a mounting medium with 
PBS:glycerol (50/50) and Hoescht 33258 (5 mmg/ml).  
The stained cells that remained attached to the plates were visualized using a 
Nikon fluorescence microscope employing a suitable filter.  
 
2.2.9- Glutathione determination 
 
Concentrations of oxidized (GSSG) and reduced (GSH) forms of glutathione were 
determined using a fluorometric method described by Hissin and Hilf (Hilf P. and Hilf 
R., 1976). This method measures both, oxidized (GSSG) and reduced (GSH) 
glutathione using o-phthalaldehyde (OPT) as a fluorescent reagent and takes 
advantage of the reaction of GSH with OPT at pH 8 and GSSG with OPT at pH 12. 
GSH can be complexed to N-ethylmaleimide (NEM) to prevent interferences of GSH 
with measurement of GSSG.  
To the sample preparation, cells were washed twice with ice cold PBS, 
ressuspended in ice cold PBS-EDTA (KH2PO4 100 mM, EDTA 5mM pH 8). Then ice 
cold HClO4 0,6M was added and the mixture was maintained in ice for 5 minutes. 
After vigorous vortex, the suspension was centrifuged at 14 000 rpm for 5 minutes 
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at 4ºC. Supernatants were collected and the pellet was ressuspended in NaOH 1N 
for protein quantification. Samples were stored at -80ºC.  
For GSH measurement, GSH standard solution or sample was added to 
phosphate-EDTA buffer (NaH2PO4 100mM, EDTA 5mM pH = 8) and OPT. The 
mixture was remained at room temperature for 15 min and then fluorescence 
detection was done with excitation and emission at 350 and 420 nm, respectively.  
For GSSG measurement the sample was added to NEM and remained 30 minutes 
and then NaOH 100 mM was added and also OPT. The mixture was remained at 
room temperature for 15 min and then fluorescence detection was performed.  
 
2.2.10- Statistical Analysis 
 
Statistical analysis was performed using GraphPad Prism 5.00 software. All the 
results are representative of at least three independent experiments. Data are 
expressed as mean + SEM. Comparisons between multiple groups were performed 
with a one-way ANOVA or by a Student’s t-test. A value of p lower than 0.05 was 
considered statistically significant.  
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Chapter 3: Experimental Results 
 
3.1- Red Wine Extract does not affect the viability 
of HT-29 cells 
 
Before examining the potential benefit of RWE in intestinal inflammation, we 
tested the cytotoxic profile of a RWE (the phenol content expressed in catechin 
equivalents of the selected RWE is 222 mg/g). For these propose, HT-29 cells were 
incubated with several concentrations of RWE (100, 200, 400 and 600 µg/ml) for 
twenty-four hours and then cell viability was evaluated by the MTT assay which 
principle was presented in the previous section.  
As shown in figure 10 RWE did not affect the viability of HT-29 cells at the 
concentrations tested.  
 
 
  
 
 
 
 
 	  	  	  	  
Figure 10. - Effect of Red Wine Extract (RWE) on HT-29 cell viability (MTT assay). 
Cells were treated with four different concentrations of RWE (100, 200, 400 and 600 µg/ml) 
for 24 hours. Cell viability was measured by following the extent of MTT reduction. Data 
represent the mean ± S.E.M. of at least four independent experiments run in duplicate and 
are expressed as percentage of control cells (100%). A-control; B-100 µg RWE/ml; C-200 µg 
RWE/ml; D-400 µg RWE/ml; E-600 µg RWE/ml. 
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3.2 - Red Wine Extract inhibits IκB degradation 
induced by TNF-α  in HT-29 cells 	  
NF-κB signaling pathway has been implicated in the pathogenesis of several 
inflammatory diseases, namely in IBD. IκB’s are a class of inhibitor protein that 
sequester NF-κB dimers in the cytosol, preventing its nuclear translocation. IκB 
degradation lead to the release of NF-κB, which translocates to the nucleus, leading 
to the expression of pro-inflammatory proteins. Therefore, IκB degradation is an 
indirect marker for the activation of NF-κB.  
To investigate the effect of RWE in the NF-κB pathway, HT-29 cells were 
incubated or not with RWE and then stimulated with TNF-α (70 ng/ml) and the levels 
of IκB degradation were determined by Western Blot in the different situations.  
As shown in figure 11, TNF-α induced a rapid degradation (15 min) of the IκB 
protein. However, a pre-incubation with several concentrations of RWE (100, 200, 
400 and 600 mµg/mL) resulted in almost complete inhibition of IκB degradation.  
 	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  
Figure 11. - Effect of Red Wine Extract (RWE) on IκB degradation in TNF-α-
stimulated HT-29 cells. Cells were pretreated with four different concentrations of RWE 
(100, 200, 400 and 600 mg/ml) for 30 min and then stimulated with TNF-α (70 ng/ml) for 15 
min. Cytosolic extracts were analyzed by Western blot using anti-human IκB antibody (Cell 
Signaling). In the bar graph, the relative expression of IkB normalized to the actin level was 
expressed as mean ± SEM from at least five independent experiments. Statistical 
significance: ***p<0.001 as compared to control cells; &&&p<0.001 and &p<0.05 as compared 
to cells stimulated with cytokines. A-Control; B-Cytokines; C-Cytokines +100 µg RWE/ml; D- 
Cytokines +200 µg RWE/ml; E-Cytokines +400 µg RWE/ml; F-Cytokines +600 µg RWE/ml. 
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3.3- Red Wine Extract inhibits IL-8 production by 
TNF-α  -stimulated HT-29 cells 	  
The NF-κB pathway activation begins gene transcription of inflammatory 
mediators, namely IL-8, a chemokine that plays a major role in mediating the 
inflammatory burst and massive infiltration of the mucosa by polymorphonuclear 
leukocytes. To investigate the effect of RWE in the production of pro-inflammatory 
proteins, the secretion of IL-8 by HT-29 cells was analysed by using enzyme-linked 
immunosorbent assay (Elisa). In the control situation IL-8 production is very reduced 
(3.22 ± 0.2 ng/ml). TNF-α induces IL-8 overproduction (108.42 ± 23.45 ng/ml). As 
shown in figure 12, RWE significantly reduced the TNF-α -induced production of IL-8 
in a dose dependent manner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12- Effect of Red Wine Extract (RWE) on IL-8 production by TNF-α  -
stimulated HT-29 cells. Cells were pretreated with four different concentrations of RWE 
(100, 200, 400 and 600 µg/ml) for 30 min and then stimulated with TNF-α (70 ng/ml) for 24 
hours. IL-8 protein secretion in culture supernatant was quantified by using an Elisa kit (R&D 
Systems). Data represent the mean ± SEM from at least three independent experiments. 
Statistical significance: ***p<0.001 as compared to control cells; &&p<0.005 and &p<0.05 as 
compared to cells stimulated with cytokines. A-Control; B- TNF-α;; C- TNF-α +100 µg 
RWE/ml; D- TNF-α +200 µg RWE/ml; E- TNF-α +400 µg RWE/ml; F- TNF-α +600 µg 
RWE/ml. 
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3.4 - Red Wine Extract supresses iNOS expression 
and inhibits nitric oxide production induced by 
cytokines in HT-29 cells 	  
 
Nitric Oxide (●NO) is a molecular mediator of many physiological processes 
including vasodilation, inflammation, immunity and neurotransmission. Large 
amounts of ●NO can destroy host tissues and impair cellular responses. It is known 
that an excessive inflammatory cytokine production can lead to the induction of iNOS 
and consequently to an excessive ●NO production.  
HT-29 cells were incubated with a cocktail of cytokines (20 ng/ml TNF-α; 10 
ng/ml IL-1; 60 ng/ml INF-γ) for one, three, six and sixteen hours and then the iNOS 
levels were determined by Western Blot. As we can see in figure 13 only at six hours 
occurred the iNOS induction.  	  	  	  
 
 
 
 
 
 
Figure 13- iNOS expression induced by cytokines in HT-29 cells. HT-29 cells were 
stimulated with cytokines (20 ng/ml TNF-α; 10 ng/ml IL-1; 60 ng/ml INF-γ) for 1, 3, 6 and 16 
h as indicated in figure. Results are representative of three independent experiments.  
 
 
To investigate the effect of RWE in the iNOS expression, HT-29 cells were pre-
treated with four different concentrations of RWE (100, 200, 400 and 600 µg/ml) for 
30 min and then stimulated with cytokines (20 ng/ml TNF-α; 10 ng/ml IL-1; 60 
ng/ml INF-γ) for six hours and the iNOS levels were determined by Western Blot.   
As shown in figure 14 A) expression of the iNOS protein was not detectable in 
unstimuled cells, but markedly increased six hours after cytokines treatment. Pre-
treatment with RWE showed a significant concentration-dependent inhibition of iNOS 
protein expression in cytokines- stimulated cells.  
Considering cells only treated with cytokines as 100%, we can observe that pre-
treatment with 100, 200, 400 and 600 µg/ml of RWE decrease iNOS expression to 
38.9, 17.05, 2.9 and 2.55 % respectively.  
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The ●NO production was measured in the supernatants after sixteen hours of 
incubation with cytokines. Results showed an expectable increase of ●NO production 
when cells were only treated with cytokines and a decrease to the control levels 
when cells were pre-treated with RWE (figure 14 B). 
The induction of iNOS was also analyzed by immunohistochemistry (figure 15). 
Cells were also pre-treated with four different concentrations of RWE (100, 200, 400 
and 600 µg/ml) for thirty minutes and then stimulated with cytokines (20 ng/ml TNF-
α; 10 ng/ml IL-1; 60 ng/ml INF-γ) for six hours. Results showed a higher induction of 
iNOS in cells treated only with cytokines and a visible decrease of the induction when 
cells were also pre-treated with RWE, even with lower concentrations of RWE. 
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Figure 14- Effect of Red Wine Extract (RWE) on iNOS expression  induced by 
cytokines in HT-29 cells. Cells were pretreated with four different concentrations of RWE 
(100, 200, 400 and 600 mg/ml) for 30 min and then stimulated with cytokines(20 ng/ml TNF-
α; 10 ng/ml IL-1; 60 ng/ml INF-γ). (A) After 6 hours of incubation, total protein extracts 
were obtained and then analysed by Western blot using anti-iNOS antibody (Santa Cruz). In 
the bar graph, the relative expression of iNOS normalized to the actin level represents the 
mean ± SEM from at least three independent experiments and are expressed as percentage 
of cells incubated with cytokines (100%). Statistical significance: ***p<0.001 as compared to 
control cells; &&&p<0.001 as compared to cells stimulated with cytokines.	  (B) After 16 hours 
of incubation, supernatants were collected and the ●NO production was measured by 
chemiluminescence.  Statistical significance: ***p<0.001 as compared to control cells; 
&&&p<0.001 as compared to cells stimulated with cytokines. 
A-Control; B-Cytokines; C-Cytokines +100 µg RWE/ml; D- Cytokines +200 µg RWE/ml; E-
Cytokines +400 µg RWE/ml; F-Cytokines +600 µg RWE/ml. 
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Figure 15 - Imunostaining for iNOS: Cells were pre-treated with four different 
concentrations of RWE (100, 200, 400 and 600 µg/ml) for 30 min and then stimulated with 
cytokines (20 ng/ml TNF-α; 10 ng/ml IL-1; 60 ng/ml INF-γ) for 6 hours.  
A-Control; B-Cytokines; C-Cytokines +100 µg RWE/ml; D- Cytokines +200 µg RWE/ml; E-
Cytokines +400 µg RWE/ml; F-Cytokines +600 µg RWE/ml. 
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3.5 - Red Wine Extract inhibits tyrosine nitration in 
cytokines-stimulated HT-29 cells	  	  
 
An increased production of ●NO would, via interaction with superoxide radical, 
yield the inflammatory stressor peroxynitrite, thus promoting a nitroxidative stress.  
One of the major consequences of the peroxynitrite is the selective nitration of 
the tyrosine residues in specific proteins, affecting protein structure and function.  
Therefore, as cytokines induced an overproduction of ●NO by HT-29 cells, we first 
analyzed, by western blot with an antibody anti-nitrotyrosine, if cytokines also 
induced nitration of the tyrosine residues in proteins. As we can see in figure 16 
(lane B), cells incubated with cytokines showed higher levels of nitrated proteins as 
compared with control cells. To determine the effect of RWE in nitrotyrosination, HT-
29 cells were pre-treated with RWE (100, 200, 400 and 600 µg/ml) for thirty minutes 
min and then stimulated with cytokines (20 ng/ml TNF-α; 10 ng/ml IL-1; 60 ng/ml 
INF-γ) for sixteen hours. RWE decreased the levels of tyrosine nitration in a dose 
dependent manner. Treatment with dithionite that converts nitrotyrosine in 
aminotyrosine proves that the bands present in figure 16 A) that disappear in figure 
16 B) are really proteins with nitrated tyrosines. 
  
 
Figure 16: Effect of RWE on tyrosine nitration in cytokines-stimulated HT-29 cells: 
HT-29 cells were pre-treated with different concentrations of RWE (100, 200, 400 and 600 
µg/ml) and stimulated with cytokines (20 ng/ml TNF-α; 10 ng/ml IL-1; 60 ng/ml INF-γ) for 16 
hours then total extracts were obtained and western blot was performed. A) Without 
treatment with dithionite B) with dithionite treatment. A-control; B-Cytokines; C- Cytokines + 
100 µg RWE/ml; D-Cytokines +200 µg RWE/ml; E-Cytokines +400 µg RWE/ml; F-Cytokines 
+600 µg RWE/ml. 
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3.6 - Red Wine Extract modifies occludin 
expression and distribution in TNF-α-stimulated 
HT-29 cells 	  
 
Intestinal epithelial cells (IECs) regulate the intestinal permeability through the 
epithelial junctions, which can be desmosomes adherent junctions or tight junctions 
(TJs). TJs are complex structures composed of different proteins such as occludins, 
proteins of the zonula occludens and proteins of the claudin family. In IBD we have 
an increase of pro-inflammatory cytokines that could lead to the impairment of tight 
junctions and consequently loss of barrier function.  
To investigate the effect of RWE in the tight junctions the distribution and 
expression of occludin will be studied by immunocytochemistry in cells pre-treated 
with several RWE concentrations and stimulated with TNF-α (70 ng/ml) overnight 
(sixteen hours). 
Immunocytochemistry results (figures 17,18) showed that RWE significatively 
alter de occludin expression and distribution in HT-29 cells, especially when HT-29 
cells were stimulated with TNF-α and pre-treated with the higher concentrations of 
RWE. There is an increase of occludin levels around cells in a dose dependent 
manner. 
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Figure 17 : Imunostaining for occludin: Cells were pre-treated with four different 
concentrations of RWE (100, 200, 400 and 600 µg/ml) for 30 min and then stimulated with 
TNF-α (plus sign) and maintained overnight (16 h). A-control; B-100 µg RWE/ml; C-200 µg 
RWE/ml; D-400 µg RWE/ml; E-600 µg RWE/ml. 
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Figure 18- Imunostaining for occludin: Cells were pre-treated with four different 
concentrations of RWE (100, 200, 400 and 600 µg/ml) for 30 min and then stimulated   with 
TNF-α (plus sign) and maintained overnight. A-TNF-α; B- TNF-α+100 µg RWE/ml; C- TNF-
α+200 µg RWE/ml; D- TNF-α+400 µg RWE/ml; E- TNF-α+600 µg RWE/ml. 
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3.7- Red Wine Extract affects the Nrf2 pathway in 
TNF-α  -stimulated HT-29 cells 	  
 
3.7.1- Evaluation of Nrf2 translocation to the nucleus 
 
 
At normal conditions, Nrf2 resides in the cytoplasm bound to a cytosolic repressor 
Keap1. However, under nitroxidative stress conditions, Nrf2 breaks free from Keap1 
and translocates into the nucleus enabling gene transcription.  
To investigate if the anti-inflammatory effect of RWE is related with the Nrf2 
pathway activation, we analyse the levels of Nrf2 by Western Blot in the cytoplasm 
and in the nucleus at various times.  
HT-29 cells were pre-treated with four different concentrations of RWE (100, 200, 
400 and 600 µg/ml) for thirty minutes and then stimulated with TNF-α (70 ng/ml) 
for three hours.  
Figure 19 show that treatment with RWE alone enhanced the Nrf2 levels in the 
cytoplasm, in a dose dependent manner. However, only treatment with 200 and 400 
µg/ml of RWE caused an increase in Nrf2 levels in the nuclear extracts (217.7±9.5 
and 141.5±38, respectively). TNF-α increases cytoplasmatic Nrf2 levels (242±17 %) 
and also induced a slightly increase of the nuclear Nrf2 levels (135±56). Cells treated 
with 100, 200 and 400 µg/ml of RWE and then stimulated with TNF-α-also presented 
higher cytoplasmatic Nrf2 levels. RWE (100, 200 and 400 µg/ml) potentiated the 
slightly increase of the nuclear Nrf2 levels induced by TNF-α  
Cells were also stimulated with TNF-α for thirty minutes minutes, one and six 
hours but in these situations the Nrf2 levels in the cytoplasm and nucleus doesn´t 
suffer significant variations (data not shown).  
Results showed that RWE seems to increase the Nrf2 expression levels in the 
cytoplasm and Nrf2 translocation to the nucleus in both, non-stimulated and TNF-α 
stimulated HT-29 cells, being this effect stronger in the later case. 
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Figure 19 -Effect of Red Wine Extract (RWE) on Nrf2 expression levels. Cells were 
pretreated with four different concentrations of RWE (100, 200, 400 and 600 mg/ml) for 30 
min and then stimulated with TNF-α for 3hours. (A) Cytoplasm; (B) Nucleus. After 3 hours 
of incubation, cytoplasmic and nuclear extracts were obtained and then analysed by Western 
blot using anti-Nrf2 antibody (R&D Systems). In the bar graphs, the relative expression of 
Nrf2 normalized to the actin level represents the mean ± SEM from at least three 
independent experiments and are expressed as percentage of control cells (100%).  
A-Control; B-100 µg RWE/ml; C-200 µg REW/ml; D-400 µg RWE/ml; E-600 µg RWE/ml; F- 
TNF-α s; G- TNF-α+100 µg RWE/ml; H-TNF-α+200 µg RWE/ml; I- TNF-α+400 µg RWE/ml; 
J- TNF-α+600 µg RWE/ml. 	  
Nrf2 
 
Actin 
Nrf2 
 
Actin 
	   62	  
3.7.2- Evaluation of the Red Wine Extract effect in Nrf2 
target genes 
 
Nrf2 regulates numerous genes through the antioxidant response element (ARE), 
such as Hemoxygenase 1 (HO-1) and glutathione related enzymes. 
HO-1 is one of the Nrf2 downstream targets. HO-1 is an essential enzyme in 
heme catabolism. This enzyme is responsible for the heme degradation into iron, 
carbon monoxide and biliverdin, the latter being subsequently converted into 
bilirubin. Several positive biological effects exerted by this enzyme have gained 
attention, as anti-inflammatory,antiapoptotic, angiogenic, and cytoprotective 
functions are attributable to carbon monoxide and/or bilirubin.  
So, as RWE seems to induce Nrf2 translocation to the nucleus, next we 
investigated the effect of RWE in the HO-1 levels by Western Blot. HT-29 cells were 
pre-treated with four different concentrations of RWE (100, 200, 400 and 600 µg/ml) 
for thirty minutes and then stimulated with TNF-α for one hour, three hours and six 
hours. The cytoplasmic extracts were obtained and western Blot was performed. 
At one and three hours of stimulation with TNF-α, there were no significant 
alterations in the HO-1 expression levels (data not shown). At 6 hours of incubation, 
RWE alone, principally 200 µg/ml, increased the levels of HO-1. The levels of HO-1 
of cells pre-treated with 200 and 400 µg/ml RWE and stimulated with TNF-α increase 
significantly when compared to the cells only stimulated with TNF-α (figure 20).  
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Figure 20 -Effect of Red Wine Extract (RWE) on HO-1 expression levels. Cells were 
pretreated with four different concentrations of RWE (100, 200, 400 and 600 mg/ml) for 30 
min and then stimulated with TNF-α for 6 hours. After 6 hours of incubation, cytoplasmic 
extracts were obtained and then analysed by Western blot using anti-HO-1 antibody (Santa 
Cruz). In the bar graphs, the relative expression of HO-1 normalized to the actin level 
represents the mean ± SEM from two independent experiments and are expressed as 
percentage of control cells (100%). Statistical significance: # p<0.05 as compared to cells 
stimulated with TNF-α. 
A-Control; B-100 µg RWE/ml; C-200 µg REW/ml; D-400 µg RWE/ml; E-600 µg RWE/ml; F- 
TNF-α s; G- TNF-α+100 µg RWE/ml; H-TNF-α+200 µg RWE/ml; I- TNF-α+400 µg RWE/ml; 
J- TNF-α+600 µg RWE/ml. 
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Glutathione is one of the most important endogenous antioxidant produced by the 
cells, participating directly in the neutralization of free radicals and reactive oxygen 
compounds, as well as the maintenance of exogenous antioxidants such as vitamins 
C and E in their reduced (active) forms. It is also essential for the immune system to 
exert its full potential, e.g. (1) modulating antigen presentation to lymphocytes, 
thereby influencing cytokine production and the type of response (cellular or 
humoral) that develops, (2) enhancing proliferation of lymphocytes thereby 
increasing magnitude of response, (3) enhancing killing activity of cytotoxic T cells 
and NK cells, and (4) regulating apoptosis, thereby maintaining control of the 
immune response.  
The oxidized and reduced glutathione levels in HT-29 cells pre-treated with four 
different concentrations of RWE (100, 200, 400 and 600 µg/ml) for thirty minutes 
and then stimulated cytokines (20 ng/ml TNF-α; 10 ng/ml IL-1; 60 ng/ml INF-γ) for 
six hours or overnight were calculated by a fluorimetric method described by Hissin 
and Hilf. This method measures both oxidized (GSSG) and reduced (GSH) 
glutathione using o-phthalaldehyde (OPT) as a fluorescent reagent and takes 
advantage of the reaction of GSH with OPT at pH 8 and GSSG with OPT at pH 12. 
GSH can be complexed to N-ethylmaleimide (NEM) to prevent interferences of GSH 
with measurement of GSSG. 	  
Results show that with six hours of stimulation reduced glutathione levels suffer a 
significant increase when cells are pre-treated with 200 and 600 µg/ml of RWE but 
non stimulated with cytokines, addition of cytokines without pre-treatment with RWE 
induces a very little increase in the reduced glutathione levels. Pre-treatment with 
RWE in cytokines stimulated cells does not significantly alter the GSH levels when 
compared with cytokines stimulated cells levels although pre-treatment with 200 
µg/ml of RWE seems to increase GSH levels (figure 21 A).  
With cytokines stimulation overnight results are different. In all conditions 
stimulated with cytokines the GSH levels decrease significantly. Pre-treatment with 
RWE extracts does not revert this effect but there are minor increases in GSH levels 
in cells pre-treated with RWE and cytokine stimulated when compared with cytokines 
stimulated cells without RWE pre-treatment (figure 21 B).   
There is no significant impact in the oxidized glutathione levels with pre-treatment 
with RWE and six hours or overnight stimulation with cytokines (data not shown). 
  
	   65	  
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21 - Effect of Red Wine Extract (RWE) on GSH levels in cytokines-
stimulated HT-29 cells. Cells were pretreated with four different concentrations of RWE 
(100, 200, 400 and 600 µg/ml) for 30 min and then stimulated with cytokines (20 ng/ml TNF-
α; 10 ng/ml IL-1; 60 ng/ml INF-γ) for (A) 6 hours, (B) Overnight. GSH levels were calculated 
using the fluorimetric method described by Hissin and Hilf. Data represent the mean ± SEM 
from at least three independent experiments. Statistical significance: ***p<0.001 as 
compared to control cells; **p<0.005 and *p<0.05 as compared to control cells. 
A-Control; B-100 µg RWE/ml; C-200 µg REW/ml; D-400 µg RWE/ml; E-600 µg RWE/ml; F- 
TNF-α s; G- TNF-α+100 µg RWE/ml; H-TNF-α+200 µg RWE/ml; I- TNF-α+400 µg RWE/ml; 
J- TNF-α+600 µg RWE/ml. 
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Chapter 4: Discussion  	  
Although the etiology of IBDs has not been fully elucidated, several studies 
suggested that genetic, environmental, microbial and immunologic factors are 
implicated in the pathogenesis of IBD. As other inflammatory disorders, IBD is 
characterised by a deregulated synthesis and release of a variety of proinflammatory 
mediators, including cytokines, reactive oxygen species (ROS) and nitric oxide (●NO), 
resulting in a disruption of epithelial barrier and excessive tissue injury.  
A specific causal treatment of IBD is still not available and the most currently 
drugs used in its treatment have serious side effects that limit their use. 
Consequently, the development of new drug treatments that combine efficacy and 
safety is an important goal in IBD therapy.  
In recent years, there has been a growing interest supported by a large number 
of experimental and epidemiological studies for the beneficial effects of dietary 
polyphenols in preventing chronic inflammatory conditions. Particularly, the efficacy 
of polyphenols in preventing and treating IBD has been suggested by several 
studies, using rodent models of IBD (Shapiro H. et al, 2007). In these studies acute 
or chronic colitis was induced by intrarectal administration of dinitrobenzene sulphate 
or trinitrobenzene sulphate, addition of dextran sulphate sodium in the drinking 
water or by knockout of the interleukin-2 genes. The administration of polyphenols 
was done orally or intraperitoneally before, during and/or after induction of colitis. 
Then rodents were killed and indices of disease were assessed between 48 h and 6 
weeks after induction of colitis (Shapiro H. et al, 2007). The polyphenols tested 
(resveratrol, EGCG/green tea extract, curcumin,, quercetin and its naturally occurring 
glycones) reduced mortality rates, diminished colonic and extracolonic signs of 
disease, colon macropathology and micropathology and/or indices of inflammation 
and autoimmunity (eg, colonic myeloper-oxidase and NF-kB activity, increased TNF-
α, IL-1b, IL-12, iNOS and reduced IL-10, Crohn’s disease 4+ T cell and neutrophil 
infiltration) (Shapiro H. et al, 2007). 
Additional studies performed in humans with ulcerative colitis or Crohn´s disease 
using curcumin provided promising results, in terms of improved clinical symptoms, 
histopathology and laboratory indices and no serious adverse effects were reported 
(Holt P. et al, 2005; Hanai H. et al, 2006).  
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However a clear understanding of the molecular mechanisms of action of 
polyphenols is crucial in the evaluation of these molecules as potential prophylactic 
and therapeutic agents in IBD.  
In this study, we show that a red wine extract, rich in polyphenols (the phenol 
content expressed in catechin equivalents of the selected RWE is 222 mg/g) may be 
useful in the prevention and/or treatment of intestinal inflammation  
As epithelial cells play an important role in intestinal inflammation, in this study, 
we have used as cellular model, HT-29 cells, a colonic epithelial cell line. HT-29 cells 
are an epithelial cell line derived from human colonic adenocarcinoma that is able to 
express differentiation features characteristic of mature intestinal cells. When 
stimulated with cytokines they can serve as a model of intestinal inflammation. 
In any study using compounds with potential beneficial effects it is important to 
evaluate their effect on cell viability to determine if the compound has a protective 
effect or whether it compromises cell viability, if so there will be not interest in 
proceed with the study. Results show that RWE doesn´t compromise cell viability in 
any of the tested concentrations for twenty-four hours (figure 10). Additionally, 
results obtained by our group show that RWE significantly protect HT-29 cells against 
cytokines-induced cell death in a dose dependent manner, therefore the studies 
were carried on (data not shown). 
Gastrointestinal inflammation is associated with a high production of 
proinflammatory cytokines, including TNF-α. Therefore, initially we tested TNF-α as 
anti-inflammatory stimulus in our cellular model.  In our model of study, TNF-α 
induced IκB degradation (figure 11), leading to the NF-κB translocation to the 
nucleus, a clear sign that induces inflammation and for that reason is a suitable 
inflammatory stimulus for this study.  
Since its discover, NF-κB has been suspected to play a key role in chronic and 
acute inflammatory diseases. NF-κB is clearly one of the most important regulators 
of pro-inflammatory gene expression. Synthesis of cytokines (e.g. TNF- α, IL-1β, IL-
6), chemokines (e.g. IL-8), adhesion molecules and acute phase proteins among 
others is mediated by NF-κB. NF-κB activation has been implicated in diverse 
inflammatory diseases, namely in inflammatory bowel disease. In fact, several 
studies have reported elevated NF-κB levels in intestinal mucosa of IBD patients 
(Ellis R. et al, 1998; Neurath M. et al, 1998; Rogler G. et al, 1998). The inhibition of 
NF-κB is generally considered as a useful strategy for treatment of inflammatory 
disorders, namely IBD, representing an important and very attractive therapeutic 
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target (Karin M. et al, 2004). Several polyphenols have been shown to exert their 
anti-inflammatory activity by modulating NF-κB activation and acting in multiple 
steps of the activation process (Rahman I. et al, 2006). For that reason the effect of 
RWE in IκB degradation was tested to find out whether the polyphenolic extract may 
interefere with the NF-κB pathway. 
Results have shown that RWE inhibits IκB degradation (figure 11), preventing NF-
κB translocation to the nucleus and consequent pro-inflammatory gene expression. 
IκB proteins are associated with the NF-κB in unstimulated cells, sequestering the 
NF-κB in the cytoplasm as an inactive non-DNA-binding form. Upon cell stimulation 
IκB proteins are rapidly phosphorylated by IκB kinase (IKK) complex on two serine 
residues that targets the inhibitor proteins for ubiquitination and subsequent 
degradation by the ubiquitin-proteosome pathway. NF-κB translocates to the nucleus 
inducing expression of various genes above mentioned.  
Polyphenols can act at multiple steps of the NF-κB pathway and, in this particular 
case, RWE inhibit the IκB degradation but it was not studied if this occur as a direct 
effect on IKK or by interfering with the interaction of IKK with IκB. Both hypotheses 
were confirmed in other cellular models of inflammation with other polyphenols 
(Yang F. et al 2001; Mackenzie G. et al, 2004).  
The modulation of the NF-κB cascade by polyphenols can also occur at late 
stages, namely by preventing the binding of NF-κB to DNA (Rasheed Z. et al, 2009), 
this aspect was not tested with RWE.  
As a further development of this study it would be interesting to study exactly 
where RWE modulate the NF-κB cascade.. It is known that polyphenols can act 
simultaneously in both early and late steps of the NF-κB cascade (Rasheed Z. et al, 
2009). RWE are a mixture of various polyphenols so is expectable that they can act 
in various steps of this pathway. Being aromatic compounds polyphenols might also 
affect the aryl hydrocarbon receptor (AhR) that interacts with the NF-κB regulating 
his activity (Potapovich A. et al, 2011) but this particular aspect of the NF-κB 
pathway was also not studied.  
Knowing that NF-κB regulates pro-inflammatory gene expression, the levels of IL-
8 were measured by Elisa. IL-8 is a primary inflammatory cytokine and one of the 
major mediators of inflammation. It is produced by many cells including epithelial 
cells in response to pro-inflammatory stimuli. This cytokine belongs to the CXC 
chemokine family and function as a chemoattractant for neutrophils and T-cells. 
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IL-8 has been implicated in various inflammatory diseases including ulcerative 
colitis (Zimmermann H. et al, 2011; Hauser W. et al, 2011). The inhibition of TNF-α-
induced IL-8 overproduction by RWE in HT-29 (figure 12), suggested that RWE can 
interfere with the recruitment of neutrophils and T-cells and thus may impede 
progression and aggravation of intestinal inflammation. Expression of the IL-8 gene 
is dependent on the activation of transcription factor NF-κB, RWE shown to suppress 
NF-κB activity and consequently IL-8 overproduction.  
Overproduction of •NO occurs during the progression of various inflammatory 
diseases in the intestinal tract (Keklikoglu N. et al, 2008) due to the induction of the 
iNOS by excessive inflammatory cytokine production. Large amounts of ●NO 
produced by cells in response to cytokines can destroy host tissues and impair 
cellular responses. Compounds able to block iNOS-induced ●NO production by the 
suppression of iNOS induction are very attractive as anti-inflammatory agents.  For 
that reason the effect of RWE in the iNOS induction was studied.  Initially we 
challenged HT-29 cells with different concentrations of TNF-α for several periods of 
time and next we evaluated the iNOS induction by Western blot. TNF-α alone did not 
induce iNOS expression. Therefore, next, we examine the cytokines requirements for 
the iNOS induction in HT-29 cells and we conclude that it is necessary a mix of 
cytokines (20 ng/ml TNF-α; 10 ng/ml IL-1; 60 ng/ml INF-γ) to induce iNOS 
expression.  
Western Blot and immunohistochemistry results showed that RWE inhibits the 
expression of iNOS stimulated by cytokines in a concentration dependent manner 
(figure 14 A). 
This effect is probably mediated by NF-κB inhibition, as reported to other 
polyphenols in previous studies where the expression of iNOS mRNA was reduced 
through prevention of the binding of NF-κB to the iNOS promoter, thereby inhibiting 
the induction of iNOS transcription (Lin Y. et al, 1997).  
To further confirm that the inhibition of iNOS induction has a real effect in the •NO 
production in cytokines-stimulated cells, the ●NO production was measured in the 
supernatants after twenty-four hours of incubation with cytokines. Results show an 
expectable increase of ●NO production when cells were only treated with cytokines 
and a decrease, to the control levels, when cells were pre-treated with RWE (figure 
14 B). Initially, we used the Griess method for ●NO determination, but given its poor 
sensitivity, it could not be used. Therefore, chemiluminescence, a method with a 
high sensitivity and selectivity, was chosen as method for ●NO determination.  
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Indirect reactions of ●NO occur when levels of ●NO are very high and they are 
specially implicated in the pro-inflammatory effects: the formation of reactive 
nitrogen species such as peroxynitrite triggers toxic events that culminate in 
citotoxicity and nitration and nitrosation of several residues in diverse proteins, 
affecting their function (ex. iron-sulfur containing enzymes, disruption of 
mitochondrial respiration) (Clancy R. et al, 1998).  
Nitrotyrosine is a product of tyrosine nitration mediated by reactive nitrogen 
species and it is considered a marker of •NO-dependent, reactive nitrogen species-
induced nitrative stress and an indicator of cell damage and inflammation.  
The effect of RWE in nytrotirosination was also investigated, and Western Blot 
results suggest that the higher concentrations of RWE effectively decrease the levels 
of tyrosine nitration (figure 16).  
Treatment with dithionite, which converts nitrotyrosine in aminotyrosine, was 
used in the samples and Western Blot was performed with non-treated and treated 
samples to confirm that the bands present really correspond to proteins with nitrated 
tyrosines. The results obtained were only preliminary because the experiment could 
not be repeated more times due to the non-disponibility of more antibody, the 
aliquots of antibody could not be used more then one or two times because they lose 
their properties of marking. To further complete the results it would be interesting to 
perform Dot Blot because that technique would provide us a more accurate notion of 
the real quantity of nitrotyrosine in the sample and if in fact RWE protect against 
nitrotyrosination.  
The microscopic observation of the cells into the plates treated with RWE lead to 
the suspicion that RWE could somehow affect the epithelial junctions. In fact, cells 
treated with RWE seems to be more condensate in aggregates then the control cells. 
Also, when cellular extracts were prepared, the suspension of cellular pellets was 
much more difficult.   
Epithelial junctions regulate the intestinal permeability maintaining the 
intercellular adhesion and regulating paracellular transport, they could be 
desmosomes, adherent junctions (AJs) and tight junctions (TJs). Impairment of the 
tight junctions seems to have higher impact in IBD pathogenesis (Clayburgh D. et al, 
2004). Elevated levels of pro-inflammatory cytokines, characteristic of IBD, lead to 
an impairment of tight junctions and consequently loss of barrier function.  
To investigate if RWE could really have an effect in the tight junctions, particularly 
in an IBD situation, the occludin expression and distribution was observed by 
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immunocytochemistry in cells pre-treated with several RWE concentrations and 
stimulated with TNF-α overnight.  
Results show that RWE significantly alter de occludin expression and distribution 
in HT-29 cells, especially when HT-29 cells were stimulated with TNF-α and pre-
treated with the higher concentrations of RWE. There is an increase of occludin 
levels around cells in a dose dependent manner.  
Occludin is an integral membrane protein specifically associated with tight 
junctions which forms a rate-limiting transport structure within the intercellular cleft 
and other studies demonstrate that this protein confers adhesiveness to the cells 
(Van Itallie C. et al, 1997; Kevil C. et al, 1998). In IBD the epithelial barrier is 
disrupted and a certain leakiness is observed in the tight junctions what makes any 
compound capable of revert this aspect very interesting as therapeutic agent.  
The results suggest that RWE could have some effect in the tight junctions 
altering the occludin expression and distribution (figure 17 and 18) but more studies 
are necessary to confirm the results and to investigate the effect of RWE in other 
tight junctions proteins and in transepithelial permeability.  
Nitroxidative stress inevitably accompanies any inflammation, changes the redox 
balance in cells and activates the redox-dependent signalling pathways. The 
transcription factor Nrf2 is the guardian of redox homeostasis and the gene families 
affected by Nrf2, ARE-containing genes, have several anti-inflammatory and 
cytoprotective actions. The role of Nrf2 in inflammatory diseases has gained 
attention in the last years particularly in cellular models like macrophages (Wang H. 
et al, 2003; Itoh K. et al 2004).  
Knowing that dietary polyphenols have shown some beneficial effects in chronic 
inflammatory conditions and in particular having study the effect of RWE in some 
inflammatory parameters it was logical to study the effect of RWE in this particular 
pathway.  
As previously explained, under normal conditions, Nrf2 resides in the cytoplasm 
bound to a cytosolic repressor Keap1. However, under nitroxidative stress conditions, 
Nrf2 breaks free from Keap1 and translocates into the nucleus enabling gene 
transcription. To investigate if the RWE suppress the inflammatory process by 
activating the Nrf2 pathway, the Nrf2 nuclear translocation was evaluated as well as 
the effect in the Nrf2 downstream targets HO-1 and glutathione.  
This investigation had some technical problems. To determine if RWE has some 
effect in the translocation of Nrf2 to the nucleus the determination of the Nrf2 levels 
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in the cytoplasm and nucleus was performed by Western Blot. It is known that the 
molecular weight of Nrf2 is around 68 KDa and it was expectable that the band in 
the membranes would appear around that value. However with the first antibody 
used this didn´t occur. The band occurred in a much lower molecular weight value 
what lead to question the reliability of the results. Other brand of antibody was then 
used, with this one, the band presumably correspondent to Nrf2 occurred at a 
molecular weight approximate of the real molecular weight of Nrf2.  
Other challenge in the investigation was the choice of the assay duration times 
because the complete kinetics of the Nrf2 translocation to the nucleus is not fully 
understood. Choosing a time where the presumable increase of Nrf2 levels in the 
nucleus was visible was not easy. 
In at concerns to the evaluation of Nrf2 translocation to the nucleus, results 
suggested that RWE increases the Nrf2 expression levels in the cytoplasm and Nrf2 
translocation to the nucleus in both, non-stimulated and TNF-α stimulated HT-29 
cells, being this effect stronger in the later case (figure 19). 
However the expectable increase in the nuclear Nrf2 levels is not statistically 
significant (figure 19). It is important to note that every process that regulates gene 
transcription is also closely regulated. The entry of Nrf2 and the time of permanency 
into the nucleus should be no exception.  
We must also take into account that western blot is not the most sensitive 
technique. It would be interesting to use other techniques to determine the levels of 
Nrf2 in the nucleus like ELISA. It was also interesting to determine if RWE really 
relieved Keap1 inhibition of Nrf2, this could be made by determining the Keap1 levels 
of expression by western blot. The ARE/Nrf2 complex could also be studied by 
electrophoretic mobility shift assay (EMSA) to determine if RWE enhances not only 
the Nrf2 translocation into the nucleus but also its binding to the ARE. 
To further confirm the effect of RWE in the Nrf2 pathway, the Nrf2 downstream 
targets HO-1 and glutathione were studied. 
In fact, after six hours of stimulation, RWE alone, principally 200 µg/ml, increased 
the levels of HO-1. The levels of HO-1 in the cells pre-treated with 200 and 400 
µg/ml RWE and then stimulated with TNF-α also increase significantly when 
compared to the cells only stimulated with TNF-α (figure 20). These results are 
according to the results related with Nrf2 nuclear translocation leading to the 
conclusion that RWE enhances HO-1 expression most likely by the Nrf2 pathway.  
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However there were also some difficulties with the determination of the HO-1 
expression levels, the bands in the western blot are not very visible even using 
various strategies in the western blot procedure to improve the quality of the results. 
For that reason and knowing that western blot is not the most accurate technique to 
gene expression determination it would be interesting to perform a quantitative real 
time PCR for HO-1 gene expression.   
It is also important to consider that dietary polyphenols can regulate HO-1 
expression via various transcription factors (Andreadi C. et al, 2006) which include 
AP-1 (via ERK and or JNK), NF-κB (Juan S. et al, 2005) as well as Nrf2 (Balogun E. et 
al, 2003). For that reason the increase in HO-1 expression levels cannot be fully 
attributed to the Nrf2 pathway.  
In at concerns to the glutathione levels it is known that Nrf2 increases glutathione 
biosynthesis. The synthesis of glutathione is achieved by the consecutive action of 
the ATP-dependent enzymes, γ-glutamylcysteine synthetase and glutathione 
synthetase. It was reported that levels of both these key enzymes are affected by 
the activity of Nrf2 (Chan J. and Kwong M., 2000). 
In a non-stimulated situation RWE seems to increase glutathione levels, however 
it does not have a major impact when cells are stimulated with cytokines for six 
hours or overnight (figure 21). Overnight stimulation induces cell death what leads to 
the observed decreases in the glutathione levels (figure 21 B). The fact that RWE 
increases glutathione levels in a non-stimulated situation is an evidence of the 
involvement of the Nrf2 pathway but it was expectable to see the same behaviour in 
a stimulated situation.  
It would be important to also study the γ-glutamylcysteine synthetase and 
glutathione synthetase expression levels to have more informative results because 
the nitroxidative stress itself could lead to major glutathione depletion and even 
though the expression of synthetizing enzymes is increased this is 
not enough to increase total glutathione levels. 
Taking in account all the results regarding the effect of RWE in the Nrf2 pathway 
there are compelling evidences that in fact this pathway is affected but further 
studies are needed to confirm these hypothesis. 
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Conclusion 	  	  
The presented work presents strong evidences that RWE can protect against 
intestinal inflammation and identifies  possible molecular mechanisms involved in the 
defence.  
Firstly, it was demonstrated that the viability of cells is not compromised when 
incubated with RWE. Under these conditions, RWE was shown to modulate cellular 
pathways preventing both the trigger and the propagation of critical inflammatory 
cascades. In particular, when incubated with the cellular model under inflammatory 
stimulus RWE prevented IκB degradation, inhibited the NF-κB pathway and 
prevented IL-8 overproduction as well as iNOS induction.  
In addition to the interference with inflammatory cascades we have also searched 
for biomarkers of inflammation-associated nitrosative stress as other possible actions 
of RWE. In this regard it was shown that RWE prevented against tyrosine nitration. 
Additionally RWE interfered with occluding expression in the tight junctions.  
This work also present some evidences that RWE can elicit their beneficial actions 
acting in the Nrf2 pathway but further studies are necessary to complement the 
obtained results.  
All together the mechanistic and regulatory data shown here support that dietary 
compounds rich in polyphenols, particularly red wine, may provide a potential benefit 
for the prevention and treatment of inflammatory diseases such as IBD. 
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Annexes  	  
Annex 1: Detailed Composition of the Red Wine Extract used in the 
experiments  
 
 
 
 
  
Total proantocianic tannins 4,1 g/L 
Total fenols 222 mg/L 
Procyanidins  
B1 351,36 mg/L 
B2 158,70 mg/L 
B3 6,98 mg/L 
B4 17,02 mg/L 
C1 47,13 mg/L 
B2-gallate 51,66 mg/L 
(+)-catechin 8,21 mg/L 
(-)-epicatechin 3,66 mg/L 
Anthocyanins  
delphinidin 3-glucoside 73,49 mg/L 
cyanidin 3-glucoside 0,00 mg/L 
 
petunidin 3-glucoside  89,75 mg/L 
 
peonidin 3-glucoside  20,89 mg/L 
 
malvidin 3-glucoside  378,91 mg/L 
 
delphinidin 3-acetylglucoside 21,82 mg/L 
 
cyanidin 3-acetylglucoside 10,47 mg/L 
 
petunidin 3-acetylglucoside 15,49 mg/L 
 
peonidin 3-acetylglucoside 17,51 mg/L 
 
delphinidin 3-cumaroilglucoside 116,68 mg/L 
 
malvidin 3-acetylglucoside 4,85 mg/L 
 
malvidin 3-cafeoilglucoside 4,66 mg/L 
 
peonidin 3-cumaroilglucoside 9,53 mg/L 
 
malvidin 3-cumaroilglucoside 83,95 mg/L 
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